Other and unspecified nerve root and plexus disorders, also in other diseases

G6_ROOTPLEXOTHUNS

peripheral nervous system disease: A disease involving the peripheral nervous system.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G54.8, G54.9, G55* Hospital discharge: ICD-9 — 353[8-9] Cause of death: ICD-10 — G54.8, G54.9, G55* Cause of death: ICD-9 — 353[8-9] 2 out of 7 registries used, show all original rules.	9411
4. Check minimum number of events None	9411
5. Include endpoints None	9411
6. Filter based on genotype QC (FinnGen only)	9074

Control definitions (FinnGen only)

Control exclude: G6_NERPLEX

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	G6_ROOTPLEXOTHUNS
CONTROL_EXCLUDE	G6_NERPLEX
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G54[8-9]\|G55
HD_ICD_9	353[8-9]
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G54[8-9]\|G55
COD_ICD_9	353[8-9]
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other and unspecified nerve root and plexus disorders, also in other diseases based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	45171	22065	22893
Only index persons	43174	21254	21920
Unadjusted period prevalence (%)
Whole population	0.63	0.63	0.64
Only index persons	0.81	0.78	0.84
Median age at first event (years)
Whole population	52.39	53.19	51.68
Only index persons	51.98	52.71	51.27

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	9074	5049	4025
Unadjusted period prevalence (%)	1.81	1.79	1.84
Median age at first event (years)	55.03	53.84	56.52

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
9411: Matched controls
94110

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

NA3BG, ,

SPAT

4.8

314.5

745

1645

WX408

NOMESCO Finland

General anesthesy, balanced

2.4

312.3

3001

15318

G56.0

ICD-10 Finland

Carpal tunnel syndrome

16.1

307.7

1744

1315

N06AA09

ATC

amitriptyline; systemic

3.7

307.7

1276

3868

G55.2

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

159.3

307.7

611

G54.0

ICD-10 Finland

Brachial plexus disorders

21.4

307.7

442

216

L03

ICPC

Low back symptom/complaint

3.9

307.7

4160

15961

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

8.7

307.7

593

725

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

45.0

307.7

539

127

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

7.2

307.7

2027

3461

N03AX16

ATC

[U] pregabalin

6.7

307.7

4571

11652

N03AX12

ATC

[U] gabapentin; oral

9.4

307.7

4114

7203

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

5.7

307.7

2217

4819

M03BX02

ATC

tizanidine; oral

3.2

307.7

7157

47172

M03BC01

ATC

orphenadrine (citrate); systemic

2.7

307.7

2935

13693

N02BF02

ATC

pregabalin; oral

5.4

307.7

1094

2221

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

6.4

307.7

663

1094

M54.9

ICD-10 Finland

Dorsalgia, unspecified

3.3

307.7

1693

5877

G56.2

ICD-10 Finland

Lesion of ulnar nerve

16.0

307.7

412

269

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

13.5

307.7

4873

6924

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

11.8

307.7

439

387

M54.3

ICD-10 Finland

Sciatica

5.1

307.7

1143

2478

M01AH05

ATC

etoricoxib; oral

2.8

307.7

6936

46823

M54.5

ICD-10 Finland

Low back pain

3.7

307.7

5053

22566

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

7.6

307.7

559

778

M79.6

ICD-10 Finland

Pain in limb

2.3

307.7

4483

26686

N02AJ06

ATC

codeine and paracetamol; systemic

3.1

307.7

5358

28253

M54.1

ICD-10 Finland

Radiculopathy

7.2

307.7

925

1412

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

7.0

307.7

1440

2364

M47.9

ICD-10 Finland

Spondylosis, unspecified

13.6

307.7

1050

863

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.7

307.7

5241

29824

WX725

NOMESCO Finland

Noninvasive ventilation

5.3

307.7

1086

2246

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

3.4

307.7

2332

8206

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

11.0

307.7

886

878

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

7.4

307.7

1223

1870

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

8.6

307.7

999

1280

AB5CT

NOMESCO Finland

Blockage of nerv root with CT guidance

28.4

307.7

311

113

N02BF01

ATC

gabapentin; oral

7.3

307.7

1945

3235

WX720

NOMESCO Finland

Own respiration

5.1

307.7

887

1900

N06AX21

ATC

duloxetine; oral

4.5

307.7

2014

5368

N02AX02

ATC

tramadol; systemic, rectal

4.2

307.7

5951

27123

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

365.7

307.7

4969

287

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

10.9

307.7

1449

1552

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

50.9

307.7

493

102

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

10.4

307.7

3081

4192

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

6.7

307.7

2113

3875

TPH04

NOMESCO Finland

Cathetrisation of vein

2.7

307.7

2662

12110

L86

ICPC

Back syndrome with radiating pain

7.4

307.7

1459

2284

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

8.5

307.7

1252

1668

G55.1

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders

110.0

307.7

977

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

15.5

307.7

841

591

M50.3

ICD-10 Finland

Other cervical disc degeneration

7.7

307.7

509

697

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

323.2

307.7

2667

115

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

9.4

307.7

465

519

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

20.8

307.7

2022

1220

Z01.8

ICD-10 Finland

Other specified special examinations

2.5

307.7

2655

12626

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

13.1

307.7

870

727

ACC51

NOMESCO Finland

Release of median nerve

118.8

307.7

864

WX704

NOMESCO Finland

Intubation

5.5

307.7

1743

3742

M54.4

ICD-10 Finland

Lumbago with sciatica

7.2

307.7

4144

9224

G54.9

ICD-10 Finland

Nerve root and plexus disorder, unspecified

143.6

307.7

399

G55.1*M51.9

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)

297.1

307.7

1079

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

19.7

307.7

263

137

XA402

NOMESCO Finland

ENMG

10.3

307.7

536

551

M48.0

ICD-10 Finland

Spinal stenosis

8.3

307.7

2772

4501

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

5.3

307.7

735

1476

G54.8

ICD-10 Finland

Other nerve root and plexus disorders

227.7

307.7

244

M43.1

ICD-10 Finland

Spondylolisthesis

5.0

305.6

686

1447

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

11.7

292.9

303

267

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.3

290.9

2998

15691

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

18.9

289.8

229

124

XX2CT

NOMESCO Finland

Other injection with CT guidance

48.9

289.8

168

WX402

NOMESCO Finland

General anaesthesia

2.4

288.7

2602

12837

ABC30

NOMESCO Finland

Decompression of cervical nerve roots

12.7

287.0

281

227

M01AB05

ATC

diclofenac; systemic, rectal

2.3

285.4

6864

50346

ACC53

NOMESCO Finland

Release of ulnar nerve

121.8

283.7

144

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.9

280.2

1496

5692

N02BE01

ATC

paracetamol; systemic, rectal

3.9

276.0

8760

72814

SPAT1153

SPAT

Removal of sutures

2.2

274.3

3260

18025

M75.1

ICD-10 Finland

Rotator cuff syndrome

2.3

271.7

2788

14493

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

5.8

261.8

496

897

M54.2

ICD-10 Finland

Cervicalgia

3.3

259.8

1076

3525

M47.82

ICD-10 Finland

Other spondylosis, cervical region

4.7

249.8

606

1360

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

8.3

244.2

325

403

N06AX16

ATC

venlafaxine; oral

2.6

242.0

1714

7497

N02AA05

ATC

oxycodone; systemic

2.5

239.4

1797

8075

ABC66

NOMESCO Finland

Decompression of lumbal spinal channel

23.3

231.3

167

WX702

NOMESCO Finland

Supraglottic ventilation device

3.5

228.8

833

2508

SPAT1263

SPAT

Sampling

2.0

226.6

4147

26512

A02BC03

ATC

lansoprazole; oral

2.1

224.1

2913

16429

A02BC02

ATC

pantoprazole; systemic

2.1

223.4

6644

50256

NAG66

NOMESCO Finland

Posterior interbody fusion of lumbar spine, 2 vertebrae

12.3

217.8

217

180

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.8

209.5

1152

4414

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

3.3

208.5

848

2734

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.2

202.3

866

2879

A02BC05

ATC

esomeprazole; systemic

1.9

198.7

4066

26651

M01AH01

ATC

celecoxib; oral

2.3

196.7

1868

9236

G56.4

ICD-10 Finland

Causalgia

75.1

193.4

104

M01AE03

ATC

ketoprofen; systemic, rectal

1.9

193.4

3621

22988

R51.80

ICD-10 Finland

Headache

2.3

192.9

1659

7859

R52.2

ICD-10 Finland

Other chronic pain

4.4

190.7

497

1177

G57.3

ICD-10 Finland

Lesion of lateral popliteal nerve

13.1

187.9

180

140

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

15.3

186.3

163

108

S18

ICPC

Laceration/cut

1.9

186.2

4289

29024

M70.6

ICD-10 Finland

Trochanteric bursitis

2.5

184.2

1368

6060

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

5.3

179.4

370

721

L01

ICPC

Neck symptom/complaint

2.3

177.9

1644

8005

Z50.1

ICD-10 Finland

Other physical therapy

3.4

177.3

664

2028

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

7.7

177.0

251

335

SPAT1301

SPAT

No procedures

1.9

176.7

2932

17758

H02AB06

ATC

prednisolone; systemic

1.8

175.3

4505

31349

M25.5

ICD-10 Finland

Pain in joint

1.9

172.6

3200

20072

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

166.5

3512

22891

ZXM20

NOMESCO Finland

Intraoperative use of computerised tomography

9.9

165.9

191

196

N06AX11

ATC

mirtazapine; oral

1.9

165.7

3305

21160

R52.1

ICD-10 Finland

Chronic intractable pain

10.0

165.7

190

194

A01

ICPC

Pain general/multiple sites

2.7

164.9

973

3845

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

163.8

4212

29121

M01AC06

ATC

meloxicam; systemic, rectal

1.8

161.4

3498

22936

G51.0

ICD-10 Finland

Bell palsy

17.1

160.8

133

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

4.5

158.7

404

938

AA1AD

NOMESCO Finland

CT of head and brain

1.9

158.2

2489

14711

G54.4

ICD-10 Finland

Lumbosacral root disorders, not elsewhere classified

66.8

157.0

M01AE02

ATC

naproxen; oral, rectal

1.8

150.2

5359

40363

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

148.2

2653

16297

2402

FHL

External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)

17.2

147.9

122

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

5.0

146.3

325

675

M01AH02

ATC

rofecoxib; oral

2.3

145.3

1235

5769

G83.4

ICD-10 Finland

Cauda equina syndrome

16.2

144.8

123

WX110

NOMESCO Finland

Infiltration anesthesia

1.8

143.2

6751

54740

L13

ICPC

Hip symptom/complaint

2.1

141.7

1711

9175

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

4.8

138.5

318

679

R03AC02

ATC

salbutamol; inhalant

1.7

138.1

5121

38602

G99.2*M47.9

ICD-10 Finland

Myelopathy in spondylosis

20.4

137.9

105

L17

ICPC

Foot/toe symptom/complaint

1.8

137.3

2632

16449

A02BC01

ATC

omeprazole; systemic

1.8

132.8

2481

15355

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.9

132.8

1925

10979

M54

ICD-10 Finland

Dorsalgia

2.2

129.9

1310

6543

R4110, ,

SPAT

2.5

129.9

913

3910

M03BC51

ATC

orphenadrine, combinations; systemic

1.8

129.1

2693

17206

TPH07

NOMESCO Finland

Cathetrisation of artery

2.3

129.0

1123

5284

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.2

128.3

1177

5658

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

128.0

3893

27623

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

6.0

126.0

225

383

M79.1

ICD-10 Finland

Myalgia

2.1

125.3

1425

7444

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.8

125.0

393

1065

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.1

124.9

1422

7430

N06AA10

ATC

nortriptyline; systemic

4.8

124.8

290

625

G44.2

ICD-10 Finland

Tension-type headache

2.1

124.1

1337

6843

R20.2

ICD-10 Finland

Paraesthesia of skin

2.6

122.8

760

3060

M43.0

ICD-10 Finland

Spondylolysis

5.0

122.1

266

543

M01AE01

ATC

ibuprofen; systemic, rectal

2.4

121.3

8634

77374

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

5.1

121.2

259

520

G99.2*M51.0

ICD-10 Finland

Lumbar and other intervertebral disc disorders with myelopathy

16.7

118.4

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.8

118.3

2159

13197

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

3.7

118.0

381

1051

N03AE01

ATC

clonazepam; systemic

2.8

117.9

626

2330

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

10.8

117.6

127

119

SPAT1097

SPAT

Recording of ECG

2.1

117.2

1352

7087

N03AX09

ATC

lamotrigine; oral

2.9

114.6

554

1960

L08

ICPC

Shoulder symptom/complaint

1.8

114.2

2023

12236

M79.7

ICD-10 Finland

Fibromyalgia

3.5

113.9

402

1177

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.6

113.9

5264

41122

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

2.7

113.8

637

2436

SPAT1310

SPAT

Counselling related to known health issue

1.7

113.8

2804

18655

ACC19

NOMESCO Finland

Transcision of peripheral nerve: other or unspecified

35.8

113.4

L12

ICPC

Hand/finger symptom/complaint

2.0

113.0

1470

8036

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.4

112.5

842

3702

M01AX17

ATC

nimesulide; oral

1.8

112.2

2122

13081

N02AJ13

ATC

tramadol and paracetamol; systemic

4.3

112.1

300

723

R06.0

ICD-10 Finland

Dyspnoea

1.8

111.8

2301

14539

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.6

111.1

3631

25971

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

110.7

4439

33395

SPAT1260

SPAT

Consultation of another employee

1.9

109.7

1607

9136

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

109.2

2540

16597

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

2.6

108.1

676

2732

Z01.9

ICD-10 Finland

Special examination, unspecified

2.7

107.6

633

2482

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

2.5

105.6

714

2994

SAA01

NOMESCO Finland

Simple examination of mouth

1.7

105.2

6716

56299

M01AH03

ATC

valdecoxib; oral

2.6

103.3

655

2663

9211

FHL

Exploration or removal of diskusprolapse

4.4

103.3

265

618

J01DB01

ATC

cefalexin; oral

1.8

103.0

7684

66968

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.2

102.7

956

4602

N05CF01

ATC

zopiclone; oral

1.7

102.7

2805

19075

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.0

102.7

1219

6436

WX400

NOMESCO Finland

Inhalation anesthesy

3.0

101.8

483

1689

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.1

101.8

1089

5533

R02

ICPC

Shortness of breath/dyspnoea

2.1

101.7

1156

6007

J01MA02

ATC

ciprofloxacin; systemic

1.6

100.5

3421

24553

J01AA02

ATC

doxycycline; systemic

1.7

99.9

7136

61086

M50.9

ICD-10 Finland

Cervical disc disorder, unspecified

7.4

99.7

145

199

A02BA02

ATC

ranitidine; systemic

1.8

99.6

1644

9681

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.2

99.5

896

4254

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

99.3

1650

9737

NAG65

NOMESCO Finland

Anterior and posterior fusion of lumbar spine

11.6

97.2

100

NF1AA

NOMESCO Finland

Hip X-ray examination

2.3

97.0

780

3531

L28

ICPC

Limited function/disability (L)

1.9

96.8

1410

7972

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

5.8

96.8

179

315

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

95.6

1765

10738

J01FF01

ATC

clindamycin; systemic

1.7

95.6

2454

16363

A06AD11

ATC

lactulose; oral

2.0

95.6

1158

6148

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

95.3

2252

14689

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.0

94.4

1202

6492

SAA03

NOMESCO Finland

Extended examination of mouth

1.6

94.4

3546

25953

TAB20

NOMESCO Finland

Epidural puncture

7.0

94.1

144

209

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.6

93.8

553

2167

M77.1

ICD-10 Finland

Lateral epicondylitis

2.2

93.5

824

3874

R42

ICD-10 Finland

Dizziness and giddiness

1.7

93.0

1903

11917

R52.9

ICD-10 Finland

Pain, unspecified

2.1

92.8

924

4559

L84

ICPC

Back syndrome without radiat pain

2.7

92.8

510

1929

M02AA07

ATC

piroxicam; topical

1.6

92.4

3059

21701

SAA02

NOMESCO Finland

Basic examination of mouth

1.6

92.3

6102

50656

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

9.5

92.1

109

116

NA3CM

NOMESCO Finland

Lumbar spine extensive MRI examination with 3 Tesla magnet

13.6

92.0

G50.1

ICD-10 Finland

Atypical facial pain

7.0

90.3

138

200

NF1DA

NOMESCO Finland

X-ray of hips

4.1

90.0

253

632

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

89.9

2513

17079

ZSA00

NOMESCO Finland

Procedure related to previous procedure classified in chapter A

12.5

89.7

AEA24

NOMESCO Finland

Removal of spinal stimulation elecrode

14.1

88.6

M76.0

ICD-10 Finland

Gluteal tendinitis

3.9

88.4

264

689

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

3.2

88.3

360

1152

UJF32

NOMESCO Finland

Coloscopy

1.7

87.9

2225

14730

SFA10

NOMESCO Finland

One-surface restoration

1.5

87.7

5008

40017

P01AB01

ATC

metronidazole; oral, rectal

1.6

86.9

3567

26500

G99.2

ICD-10 Finland

Myelopathy in diseases classified elsewhere

14.2

86.9

M16.1

ICD-10 Finland

Other primary coxarthrosis

2.0

86.4

986

5114

G57.6

ICD-10 Finland

Lesion of plantar nerve

5.6

86.3

164

296

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

86.1

1632

9973

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

85.8

977

5062

M03BX01

ATC

baclofen; systemic

4.2

85.8

231

559

M54.6

ICD-10 Finland

Pain in thoracic spine

2.3

85.2

713

3276

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.4

85.2

624

2707

R01AD09

ATC

mometasone; nasal

1.5

84.9

4127

31767

G50.0

ICD-10 Finland

Trigeminal neuralgia

7.8

84.8

117

151

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.9

84.5

1267

7207

M01AX01

ATC

nabumetone; oral

2.9

84.4

416

1484

J01DA09

ATC

[U] cefadroxil

1.6

84.0

2401

16360

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

3.0

83.9

381

1299

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

2.3

83.8

650

2892

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.3

83.5

659

2953

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

7.8

83.5

116

151

ABC60

NOMESCO Finland

Decompression of cervical spinal cord

8.2

83.2

110

135

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.1

82.9

804

3920

G99.2*M47.1

ICD-10 Finland

Spondylogenic compression of spinal cord

8.1

81.7

110

138

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

81.5

1561

9554

L15

ICPC

Knee symptom/complaint

1.7

81.3

2021

13276

R96

ICPC

Asthma

2.1

81.0

867

4388

NAU20

NOMESCO Finland

Removal of internal fixation device from spine or neck

11.6

80.8

L02

ICPC

Back symptom/complaint

2.0

80.8

923

4784

UKC02

NOMESCO Finland

Cystoscopy

1.8

80.1

1284

7449

J01FA10

ATC

azithromycin; systemic

1.5

80.0

5187

42216

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.4

79.5

569

2441

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

2.0

78.9

935

4908

G54.2

ICD-10 Finland

Cervical root disorders, not elsewhere classified

40.2

78.8

N02AC04

ATC

dextropropoxyphene; oral

3.2

78.4

314

994

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.1

78.3

823

4136

WX290

NOMESCO Finland

Other blockage of nerve

1.5

78.1

4253

33330

N05AH04

ATC

quetiapine; oral

1.7

77.3

1557

9651

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

2.3

77.3

614

2757

M96.0

ICD-10 Finland

Pseudarthrosis after fusion or arthrodesis

9.5

76.8

UDC00

NOMESCO Finland

Ear microscopy

2.2

76.6

685

3231

J01DA01

ATC

[U] cefalexin

1.5

76.3

5459

45135

R05

ICPC

Cough

1.6

76.2

2044

13658

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.1

76.0

777

3862

M54.8

ICD-10 Finland

Other dorsalgia

2.6

75.9

454

1790

G56.3

ICD-10 Finland

Lesion of radial nerve

13.2

75.8

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

75.8

2123

14338

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

75.7

4664

37390

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

3.0

75.1

335

1130

R09

ICPC

Sinus symptom/complaint

2.1

74.8

765

3803

SFA20

NOMESCO Finland

Two-surface restoration

1.5

74.6

5361

44272

SPAT1262

SPAT

Handing over of treatment supplies

1.7

74.5

1452

8909

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

3.7

74.1

243

677

G551, M501,

ICD-10 Finland

+∞

74.0

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.0

73.7

821

4211

NAG67

NOMESCO Finland

Posterior interbody fusion of lumbar spine, more than 2 vertebrae

33.7

73.6

L83

ICPC

Neck syndrome

5.9

73.1

132

227

N01

ICPC

Headache

2.0

73.0

909

4850

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.6

72.6

431

1692

M53.2

ICD-10 Finland

Spinal instabilities

6.0

72.3

128

216

M01AX05

ATC

glucosamine; oral

1.7

72.0

1451

8979

G552, M501,

ICD-10 Finland

+∞

72.0

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

71.7

2587

18489

J01FA09

ATC

clarithromycin; systemic

1.5

71.7

2779

20178

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

5.1

71.0

150

298

Z01.2

ICD-10 Finland

Dental examination

1.5

71.0

4015

31492

M65.3

ICD-10 Finland

Trigger finger

2.7

70.6

380

1420

G47.3

ICD-10 Finland

Sleep apnoea

1.6

70.2

2083

14223

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

5.0

70.1

153

313

K02.1

ICD-10 Finland

Caries of dentine

1.5

69.3

5296

43964

SPAT1254

SPAT

Administration of medicine

1.8

69.1

1134

6608

JN3AD

NOMESCO Finland

Abdominal CT examination

1.9

69.0

1018

5739

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

3.7

68.3

218

596

ZXE20

NOMESCO Finland

More than three and less than five hours

1.8

68.2

1141

6684

ABD99

NOMESCO Finland

Other operation on spinal cord or nerve for pain or impaired function

14.6

68.1

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.9

67.7

334

1191

OAA65, ,

SPAT

1.7

67.5

1527

9733

M51.2

ICD-10 Finland

Other specified intervertebral disc displacement

7.1

67.5

101

143

N07BC02

ATC

methadone; systemic

10.5

67.4

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

67.0

2516

18090

M01AB55

ATC

diclofenac, combinations; oral

2.3

66.9

557

2548

NAG41

NOMESCO Finland

Anterior fusion of cervical spine with fixation

7.6

66.5

125

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.3

66.4

541

2453

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

66.2

604

2868

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.6

66.0

386

1504

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

65.9

884

4828

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.4

65.7

474

2039

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.8

65.6

1009

5758

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.0

65.1

817

4363

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.0

64.7

296

1013

3540A

ICD-9 Finland

Mononeuritis of upper limb and mononeuritis multiplex, Carpal tunnel syndrome

+∞

64.6

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

64.6

2440

17539

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

8.4

64.6

101

NA1BG, ,

SPAT

3.5

64.5

221

634

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.9

64.4

833

4493

J01CA04

ATC

amoxicillin; systemic

1.5

64.4

7334

65407

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

64.0

1120

6643

NG1DA

NOMESCO Finland

X-ray of knees

3.8

63.3

198

534

ZXC95

NOMESCO Finland

Use of surgical navigator

4.3

63.3

166

394

D01

ICPC

Abdominal pain/cramps general

1.8

62.9

974

5565

R01AD58

ATC

fluticasone, combinations; nasal

1.5

62.6

2187

15439

R01BA52

ATC

pseudoephedrine, combinations; oral

1.5

62.6

2652

19507

L14

ICPC

Leg/thigh symptom/complaint

2.1

62.3

668

3372

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.3

62.1

489

2185

P03

ICPC

Feeling depressed

1.9

62.0

826

4499

SPAT1058

SPAT

PEF monitoring instruction

2.0

61.6

690

3538

WZA90

NOMESCO Finland

Other medical or dental certificate

1.6

61.6

1969

13621

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.1

61.5

661

3339

XF402

NOMESCO Finland

ECG with work load test

1.9

61.3

874

4865

M89.0

ICD-10 Finland

Algoneurodystrophy

6.1

61.3

106

175

XKC03

NOMESCO Finland

Water cystometry

2.9

61.1

289

1007

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.6

60.9

1904

13101

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.7

60.5

1156

7024

AEA20

NOMESCO Finland

Removal of impulse generator of stimulation device in the nervous system

18.6

60.4

J02AC01

ATC

fluconazole; systemic

1.5

60.3

3356

25998

XG410

NOMESCO Finland

Flow-volume spirometry

2.6

60.1

360

1419

WX320

NOMESCO Finland

Spinalanesthesy

1.6

59.9

1987

13847

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.1

59.8

597

2934

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

3.0

59.7

272

928

G99.2*M50.0

ICD-10 Finland

Cervical disc disorder with myelopathy

7.5

59.7

114

N05BA04

ATC

oxazepam; oral

1.5

59.6

2140

15174

N04BC05

ATC

pramipexole; oral

2.1

59.1

627

3152

WX200

NOMESCO Finland

Interscalenous plexus blockade

3.3

59.1

221

671

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.8

58.9

888

5028

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.8

58.6

989

5794

G56.9

ICD-10 Finland

Mononeuropathy of upper limb, unspecified

9.4

58.0

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.0

57.9

266

912

Z46.9

ICD-10 Finland

Fitting and adjustment of unspecified device

4.6

57.8

138

304

SPAT1240

SPAT

Therapeutic discussion

1.8

57.8

893

5094

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.9

57.2

276

973

NA3BM

NOMESCO Finland

Lumbar spine MRI examination with 3 Tesla magnet

9.4

57.1

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

3.6

57.1

193

549

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.9

57.0

797

4405

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

56.9

996

5897

KMAK, ,

NOMESCO Finland

1.4

56.7

4574

37744

C07AB07

ATC

bisoprolol; oral

1.4

56.6

3763

30015

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.8

56.5

999

5931

N06AB04

ATC

citalopram; systemic

1.6

56.4

1743

11935

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

56.0

1507

9989

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

2.3

56.0

465

2123

OAB93, ,

SPAT

2.1

56.0

569

2814

C10AA07

ATC

rosuvastatin; oral

1.5

55.9

2686

20165

HAMTE, ,

NOMESCO Finland

4.9

55.8

122

250

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

55.7

1667

11328

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.1

55.6

238

784

C01DA14

ATC

isosorbide mononitrate; oral

1.8

55.6

945

5545

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.8

55.5

850

4834

D07AC01

ATC

betamethasone; topical

1.4

55.3

3043

23423

OAB50, ,

SPAT

2.2

55.2

494

2326

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.8

54.9

285

1045

R03BA05

ATC

fluticasone; inhalant

1.6

54.8

1502

9995

M48.9

ICD-10 Finland

Spondylopathy, unspecified

7.6

54.6

102

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

3.2

54.6

225

725

NBG00

NOMESCO Finland

Plastic operation on acromioclavicular joint

3.6

54.4

183

519

L29

ICPC

Musculoskeletal sympt/complt other

1.9

54.4

727

3958

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

54.3

2074

14855

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

54.2

1564

10531

NA3CG, ,

SPAT

4.0

54.2

154

388

ABC50

NOMESCO Finland

Decopression of cervical spinal canal and nerve roots

11.8

54.0

X58

ICD-10 Finland

Exposure to other specified factors

1.7

53.9

1209

7653

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.9

53.9

746

4107

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.8

53.8

965

5747

G57.1

ICD-10 Finland

Meralgia paraesthetica

4.3

53.8

138

322

N93

ICPC

Carpal tunnel syndrome

6.7

53.7

128

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.0

53.7

602

3086

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.3

53.5

411

1815

J01EA01

ATC

trimethoprim; systemic

1.5

53.3

1995

14220

K30

ICD-10 Finland

Functional dyspepsia

1.8

53.1

955

5692

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.1

52.8

498

2392

G04CA02

ATC

tamsulosin; oral

1.6

52.5

1666

11454

N06AX26

ATC

vortioxetine; oral

2.0

52.5

631

3314

SFA30

NOMESCO Finland

Three-surface restoration

1.4

52.5

3736

30032

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

52.3

4805

40309

R75

ICPC

Sinusitis acute/chronic

2.2

52.2

433

1975

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

2.2

52.2

455

2119

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.5

51.8

2142

15571

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

4.8

51.7

117

247

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

4.4

51.5

131

304

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

51.1

1668

11532

R74

ICPC

Upper respiratory infection acute

1.4

51.0

2667

20268

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.0

51.0

547

2758

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

2.8

51.0

268

989

WX002

NOMESCO Finland

Sedation and analgesia

1.6

50.9

1524

10337

N03AF01

ATC

carbamazepine; oral, rectal

2.4

50.8

377

1641

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.1

50.7

476

2283

C10AX09

ATC

ezetimibe; oral

1.6

50.5

1273

8288

WVA20, ,

SPAT

2.8

50.3

257

934

R03DC03

ATC

montelukast; oral

1.6

50.3

1381

9179

ZXA05

NOMESCO Finland

Left side

1.5

50.0

1822

12892

C03CA01

ATC

furosemide; systemic

1.5

49.9

1919

13730

N05BA01

ATC

diazepam; systemic, rectal

1.7

49.8

1054

6562

N05CF02

ATC

zolpidem; oral

1.6

49.7

1486

10068

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

49.6

2999

23371

SPAT1081

SPAT

Cardiorespiratory global assessment

2.2

49.3

432

2015

D02

ICPC

Abdominal pain epigastric

2.1

49.2

517

2587

L16

ICPC

Ankle symptom/complaint

1.7

48.8

915

5511

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

48.8

3778

30679

WZA00

NOMESCO Finland

Concise certificate

2.0

48.7

561

2901

SPAT1229

SPAT

Assessment of need for aid

2.0

48.6

553

2848

G57.8

ICD-10 Finland

Other mononeuropathies of lower limb

12.8

48.6

SAA04

NOMESCO Finland

Special examination of mouth

2.2

48.5

442

2095

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

3.7

48.4

153

416

XQ855, ,

SPAT

4.7

48.4

112

241

C08CA01

ATC

amlodipine; oral

1.4

48.3

2928

22804

K59.09

ICD-10 Finland

Constipation, unspecified

2.0

48.1

514

2587

J01FA06

ATC

roxithromycin; oral

1.4

48.0

3275

26022

N06AB10

ATC

escitalopram; oral

1.5

47.8

1719

12116

E66.01

ICD-10 Finland

Obesity due to excess calories

1.8

47.7

747

4270

OAA81, ,

SPAT

2.5

47.7

315

1301

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

2.4

47.6

326

1368

M01AC01

ATC

piroxicam; systemic, rectal

1.7

47.6

1054

6636

C10AA05

ATC

atorvastatin; oral

1.4

47.5

3257

25884

G04BD12

ATC

mirabegron; oral

1.7

47.2

879

5282

R53

ICD-10 Finland

Malaise and fatigue

1.5

47.0

1850

13276

A11

ICPC

Chest pain NOS

1.9

46.9

655

3612

D06

ICPC

Abdominal pain localized other

1.8

46.9

708

4001

SGA01

NOMESCO Finland

Emergency treatment

1.6

46.8

1452

9908

NBF25

NOMESCO Finland

Operation for humeroscapular osteochondritis, arthroscopic

2.9

46.8

223

781

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

46.7

1163

7541

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

46.7

1090

6956

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

2.8

46.6

240

876

R07.3

ICD-10 Finland

Other chest pain

1.8

46.5

826

4897

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

46.2

1768

12612

SPAT1044

SPAT

Tympanometry

3.0

45.9

203

682

XF600, ,

SPAT

2.7

45.8

244

907

H01

ICPC

Ear pain/earache

1.7

45.6

899

5486

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.1

45.5

422

2014

S06.0

ICD-10 Finland

Concussion

1.7

45.5

839

5028

SPAT1202

SPAT

Intra-articular injection

2.7

45.3

251

952

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

45.2

922

5679

RF210, ,

NOMESCO Finland

2.7

45.2

248

936

L85

ICPC

Acquired deformity of spine

9.1

45.1

R06AE07

ATC

cetirizine; oral

1.4

45.0

3677

29997

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.7

44.9

844

5082

TQW40, ,

SPAT

1.9

44.8

612

3351

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.7

44.7

953

5937

A02BC04

ATC

rabeprazole; oral

1.8

44.7

754

4404

K10.3

ICD-10 Finland

Alveolitis of jaws

2.1

44.4

415

1985

M02AA10

ATC

ketoprofen; topical

1.6

44.4

1259

8409

H04.10

ICD-10 Finland

Dry eye syndrome

1.7

44.4

920

5687

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

44.4

1717

12262

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

2.1

44.4

451

2228

AWE00

NOMESCO Finland

Reoperation for deep heamorrhage in surgery of the nervous system

13.7

44.2

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.9

44.1

546

2892

R13

ICD-10 Finland

Dysphagia

2.0

44.0

536

2824

C07AA05

ATC

propranolol; systemic

1.5

44.0

1672

11896

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.7

43.9

235

875

TAB00

NOMESCO Finland

Lumbar puncture

2.2

43.9

383

1784

L09

ICPC

Arm symptom/complaint

2.2

43.8

394

1857

B01AB05

ATC

enoxaparin; parenteral

1.4

43.8

2474

18966

ZXD05

NOMESCO Finland

Urgent procedure

1.4

43.7

2420

18481

NA3CF

NOMESCO Finland

Lumbar spine extensive MRI examination with median intensity magnet

8.3

43.6

P01

ICPC

Feeling anxious/nervous/tense

1.7

43.5

895

5521

G43.9

ICD-10 Finland

Migraine, unspecified

2.0

43.3

480

2448

WX308

NOMESCO Finland

Sacral anesthesy

8.4

43.2

ZXA00

NOMESCO Finland

Right side

1.5

43.2

1913

14023

R01AD12

ATC

fluticasone furoate; nasal

1.4

43.0

2666

20754

M67.0

ICD-10 Finland

Short Achilles tendon (acquired)

4.9

42.9

197

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.0

42.9

476

2428

M01AE51

ATC

ibuprofen, combinations; systemic

3.5

42.9

149

432

A01AB09

ATC

miconazole; local oral

1.8

42.8

655

3714

P76

ICPC

Depressive disorder

1.9

42.8

537

2858

G57.0

ICD-10 Finland

Lesion of sciatic nerve

16.4

42.7

WW502

NOMESCO Finland

Autotransfusion

5.2

42.6

172

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

42.5

981

6233

XQ845

NOMESCO Finland

Dermatoscopy

3.2

42.5

174

559

EBA00

NOMESCO Finland

Extraction of tooth

1.4

42.4

2887

22814

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.2

42.2

354

1622

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.6

42.2

1035

6675

L11

ICPC

Wrist symptom/complaint

1.8

42.2

631

3553

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.0

42.1

464

2360

WX120

NOMESCO Finland

Intravenous local anesthesy of arm

4.6

42.1

100

220

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.3

41.9

311

1354

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

3.8

41.7

129

346

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

5441

35187

2.30

307.65

2.8

2.5

—

(3022217) INR in Platelet poor plasma by Coagulation assay

5065

33069

2.15

280.13

9.9

13.4

1.17

1.23

inr

2.72

1171

9764

(3047181) Lactate [Moles/volume] in Blood

828

2169

4.09

279.80

5.7

6.4

1.24

1.29

mmol/l

0.82

732

1911

(3013826) Glucose [Moles/volume] in Serum or Plasma

6008

43185

2.08

241.55

5.2

4.6

6.56

6.64

mmol/l

2.40

5612

40346

(3013707) Erythrocyte sedimentation rate by Westergren method

7258

56249

2.27

237.38

5.2

3.8

10.90

11.44

mm/h

3.03

6834

52297

(3039000) Anion gap in Blood

627

1531

4.32

231.87

6.2

7.5

10.91

11.30

mmol/l

2.01

566

1373

(3018572) Chloride [Moles/volume] in Blood

627

1532

4.31

231.67

6.2

7.5

105.10

105.22

mmol/l

0.23

566

1374

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3695

23097

1.99

211.27

2.8

2.5

65.16

61.05

u/l

0.28

3434

21386

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

829

2740

3.22

195.29

5.6

5.4

1.82

1.69

2.66

767

2563

(3037467) Urinalysis macro (dipstick) panel - Urine

6657

51538

2.00

194.00

5.2

4.0

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

819

2706

3.22

192.98

5.7

5.5

0.97

0.90

5.45

757

2536

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3429

21592

1.93

185.94

2.4

2.1

169.90

212.35

u/l

3.20

3225

20283

(3024561) Albumin [Mass/volume] in Serum or Plasma

4496

31395

1.83

171.82

4.9

36.26

35.81

g/l

6.81

4161

29266

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2239

12781

1.99

157.49

1.3

24.98

31.48

iu/ml

1.78

777

4139

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4890

35625

1.78

156.58

6.8

6.7

1.22

1.21

mmol/l

0.96

4116

30248

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

7124

58536

1.89

147.32

7.7

7.5

74.38

77.27

u/l

9.14

6827

55325

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3765

25792

1.77

145.96

3.5

3.3

30.84

34.59

u/l

3.50

3580

24461

(3008152) Bicarbonate [Moles/volume] in Arterial blood

986

4194

2.51

142.90

6.5

7.4

24.82

24.56

mmol/l

1.51

915

3994

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2084

12024

1.94

139.83

1.3

1.2

8.65

12.20

u/ml

1.56

645

4893

(3019550) Sodium [Moles/volume] in Serum or Plasma

8902

80126

3.05

139.14

18.3

14.3

139.66

139.71

mmol/l

1.45

8788

78205

(3031040) Bacteria [#/volume] in Urine by Automated count

6112

48324

1.76

139.13

5.1

4.0

1643.26

1489.90

e6/l

0.05

614

(3023103) Potassium [Moles/volume] in Serum or Plasma

8913

80437

3.04

135.49

18.4

14.5

3.98

3.96

mmol/l

8.29

8785

78360

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2297

13816

1.88

135.08

4.3

3.5

295.14

548.13

ng/l

1.93

1658

10376

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

5116

38779

1.70

133.03

5.4

6.4

10.03

11.36

umol/l

22.27

4863

36881

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

8742

78271

2.64

132.33

16.8

12.8

20.08

23.42

mg/l

18.99

7321

61105

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1167

5550

2.26

130.74

3.1

2.8

100.21

176.63

ng/l

18.49

1077

5026

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

906

3890

2.47

128.11

7.7

10.6

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3821

26992

1.70

127.63

4.0

3.2

31.90

44.20

ng/l

2.12

2473

17345

(3019060) Gas panel - Arterial blood

969

4404

2.34

120.33

5.2

5.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

8107

71233

2.00

114.71

5.3

4.5

1.80

2.15

mu/l

4.31

7559

65723

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3951

28734

1.65

114.09

2.0

1.9

99.25

96.31

pmol/l

3.11

2078

15131

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

7014

59080

1.73

112.50

4.3

3.9

14.58

14.68

pmol/l

3.03

6456

54137

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4325

32277

1.63

111.85

5.6

6.0

1.21

mmol/l

0.35

3941

29567

(3026008) Bacteria identified in Urine by Culture

3012

20582

1.68

109.77

3.4

2.9

—

(40761511) CBC panel - Blood by Automated count

8959

82364

2.83

106.65

17.3

11.8

—

(3019150) Specific gravity of Urine by Refractometry

2378

15512

1.71

101.61

4.0

3.7

1.02

kg/l

0.66

480

2281

(3018010) Neutrophils/100 leukocytes in Blood

4687

36345

1.58

98.44

6.1

5.9

56.08

57.01

6.67

4419

34165

(3037522) Nuclear Ab [Titer] in Serum

1718

10322

1.81

97.26

1.4

1.3

430.99

527.76

titre

1.79

342

2140

(3019069) Monocytes/100 leukocytes in Blood

4621

35826

1.57

96.33

6.5

6.4

8.44

8.55

1.79

4362

33630

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

6475

54305

1.62

95.72

3.7

3.0

50.90

47.58

u/l

2.11

6115

51051

(3002030) Lymphocytes/100 leukocytes in Blood

4729

36907

1.57

95.37

6.2

6.1

29.18

28.18

9.12

4472

34720

(3006504) Eosinophils/100 leukocytes in Blood

4592

35623

1.56

94.94

6.1

2.94

2.85

1.92

4326

33384

(40760892) CBC W Ordered Manual Differential panel - Blood

4575

35648

1.55

91.41

6.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1203

6593

1.95

90.27

7.0

8.7

125.11

122.11

g/l

5.57

1135

6421

(3022096) Basophils/100 leukocytes in Blood

4428

34486

1.54

87.07

6.1

0.70

0.69

0.82

4159

32229

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2226

14839

1.66

85.18

1.7

1.6

85281806.11

30801812.56

pmol/l

2.07

1848

12441

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1299

7433

1.87

85.09

1.9

1.7

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1745

10903

1.74

85.08

2.0

1.8

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1298

7467

1.86

83.49

1.9

1.7

—

(3016502) Oxygen saturation in Arterial blood

1244

7072

1.87

83.03

6.6

8.3

96.59

95.78

7.32

1167

6826

(3013115) Eosinophils [#/volume] in Blood

4904

39310

1.52

82.45

5.9

6.1

0.20

0.19

e9/l

2.15

4486

34578

(3044640) Blood type and Crossmatch panel - Blood

3219

23613

1.55

81.65

2.4

2.3

—

(3019198) Lymphocytes [#/volume] in Blood

4870

39041

1.51

81.41

5.8

5.9

1.98

1.93

e9/l

1.77

4491

34632

(3019309) Folate [Moles/volume] in Red Blood Cells

1874

12106

1.68

80.28

1.8

1.7

1123.54

1170.78

nmol/l

1.56

1481

9169

(3003396) Base excess in Arterial blood by calculation

1348

7952

1.81

79.62

6.6

7.8

1.59

0.99

mmol/l

8.60

1037

6368

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

7983

71701

1.75

79.48

6.3

5.2

39.83

39.14

mmol/mol

8.71

7500

66858

(3006315) Basophils [#/volume] in Blood

4739

37982

1.50

77.88

5.8

5.9

0.04

e9/l

4.84

4297

32878

(3001604) Monocytes [#/volume] in Blood

4730

37901

1.50

77.79

5.7

5.9

0.59

0.58

e9/l

3.04

4298

32836

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1342

7977

1.80

77.08

6.6

7.8

5.10

5.09

kpa

0.09

1256

7640

(3027801) Oxygen [Partial pressure] in Arterial blood

1341

7973

1.80

76.95

6.6

7.8

12.35

12.70

kpa

1.68

1257

7635

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

8333

75993

1.84

76.02

5.0

4.3

5.93

5.87

mmol/l

4.57

7758

70032

(3020682) Albumin/Creatinine [Ratio] in Urine

3008

22012

1.54

75.76

3.8

6.94

8.85

mg/mmol

1.77

1881

13951

(3035350) Ketones [Presence] in Urine by Test strip

4582

36746

1.48

73.28

4.0

3.4

0.00

estimate

0.10

760

7175

(3002385) Erythrocyte distribution width [Ratio]

7652

68393

1.64

72.32

18.4

15.4

15.14

14.83

2.52

7570

67186

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2443

17234

1.56

71.80

2.3

2.2

2.63

2.88

mg/l

7.14

2124

14766

(3009261) Glucose [Presence] in Urine by Test strip

4610

37135

1.47

71.33

4.0

3.4

0.00

estimate

0.09

678

6683

(3012516) Albumin [Mass/volume] in Urine

2857

20933

1.52

70.37

3.3

3.2

966.93

407.87

mg/l

3.51

1741

13315

(3009508) Creatinine [Moles/volume] in Urine

3042

22620

1.51

69.70

3.3

3.1

7.98

7.85

mmol/l

0.72

2613

19211

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2359

16613

1.56

69.46

1.8

1.7

0.94

1.15

mg/l

2.88

1817

12673

(3021601) Nitrite [Presence] in Urine by Test strip

4531

36782

1.45

64.86

5.5

4.6

0.00

estimate

0.20

705

6882

(3023368) Bacteria identified in Blood by Culture

2582

18791

1.52

64.49

4.2

4.3

—

(3021960) Folate [Moles/volume] in Serum or Plasma

2225

15690

1.55

64.30

1.6

1.5

21.04

20.42

nmol/l

1.05

1933

13520

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

8965

84527

2.28

64.12

11.8

9.8

28.24

27.27

u/l

4.39

8731

81776

(3008898) HLA-B27 [Presence]

561

2639

2.20

62.91

1.1

—

(3044889) 12 lead EKG panel

6275

54332

1.46

62.49

4.1

3.5

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4054

32451

1.44

61.36

3.0

2.8

114.66

131.50

ug/l

4.85

3781

30280

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2742

20372

1.49

61.31

1.9

1.6

1.50

1.39

mmol/l

5.72

2324

17241

(4200892) Spirometry reversibility

922

5228

1.85

60.98

1.5

1.4

—

(3042936) Bacteria identified in Isolate by Culture

1545

10128

1.63

60.58

2.2

2.0

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3632

28547

1.44

60.40

4.2

3.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2281

16431

1.51

58.85

1.3

1.2

1.75

1.78

u/ml

0.03

483

4561

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

892

5064

1.84

58.67

2.5

2.3

18.98

23.25

au/ml

0.90

457

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1103

6699

1.73

57.63

2.2

362.16

372.21

nmol/l

0.94

996

6184

(3013512) EKG study

2765

20789

1.47

57.40

4.6

3.6

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

5206

43905

1.42

57.18

7.9

9.4

4.15

4.05

e9/l

2.56

4720

38304

(3017732) Neutrophils [#/volume] in Blood

921

5349

1.80

56.10

2.8

2.9

4.14

4.75

e9/l

2.03

774

4417

(3009542) Hematocrit [Volume Fraction] of Blood

9208

88323

2.97

55.45

24.4

18.9

40.10

40.86

6.44

7963

83393

(3010813) Leukocytes [#/volume] in Blood

9215

88491

2.99

54.10

24.4

18.8

6.83

6.63

e9/l

18.46

9108

86106

(3007461) Platelets [#/volume] in Blood

9209

88413

2.94

53.91

24.5

18.8

254.48

252.47

e9/l

2.38

9114

86279

(3026361) Erythrocytes [#/volume] in Blood

9212

88492

2.94

53.19

24.4

18.8

4.52

4.54

e12/l

4.65

9104

86149

(3024731) MCV [Entitic volume]

9211

88479

2.93

53.16

24.3

18.7

90.95

90.88

0.86

9152

87386

(3035941) MCH [Entitic mass]

9210

88472

2.92

53.01

24.3

18.7

30.42

30.32

7.76

9151

87378

(3015736) pH of Urine

3699

29683

1.41

52.47

3.7

3.1

5.81

5.84

0.28

267

2695

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

452

2096

2.21

52.39

1.1

3.31

6.29

u/ml

1.25

302

(3000963) Hemoglobin [Mass/volume] in Blood

9211

88517

2.91

52.39

24.6

18.9

136.75

136.85

g/l

0.30

9155

87422

(3041096) Erythrocytes [Presence] in Urine by Automated

2685

20364

1.45

52.18

3.6

3.0

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

808

4622

1.82

51.59

1.3

55.20

50.89

au/ml

0.18

265

(3007853) Bacteria identified in Skin by Aerobe culture

1285

8377

1.62

50.75

1.8

1.7

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3783

30601

1.40

50.62

2.4

2.2

76.69

76.59

nmol/l

0.07

3451

27861

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

8446

78959

1.68

49.47

4.9

4.2

4.73

4.74

mmol/l

0.47

7928

73957

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

8541

80161

1.71

48.29

5.4

4.6

2.80

2.84

mmol/l

3.11

7981

74686

(36660697) Celiac disease serology panel - Serum

945

5830

1.69

46.06

1.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2382

18014

1.43

45.87

2.4

2.3

—

(3048689) Calprotectin [Mass/mass] in Stool

1376

9345

1.55

45.18

2.1

2.3

140.79

132.10

ug/g

0.30

1091

7427

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

647

3639

1.84

43.44

2.6

2.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

8367

78460

1.60

43.25

4.8

4.2

1.43

1.46

mmol/l

10.92

7827

73164

(3015171) Extractable nuclear Ab [Units/volume] in Serum

539

2887

1.92

42.13

1.3

1.2

0.98

1.06

u/ml

0.04

263

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2440

18822

1.40

41.14

2.9

822.12

1189.76

ng/l

5.31

2021

16051

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

373

1773

2.15

40.58

1.3

518.33

506.62

mg/l

0.15

352

1686

(3000330) Specific gravity of Urine by Test strip

602

3410

1.82

39.42

3.5

3.3

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

333

1543

2.20

38.63

1.2

3.74

3.73

mmol/l

0.09

305

1455

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1276

8800

1.52

38.55

1.5

1.6

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2548

19993

1.38

38.22

2.7

2.5

3826.79

3914.27

umol/l

0.04

2251

17729

(3044290) Cell count panel - Cerebral spinal fluid

321

1478

2.21

37.83

1.2

1.4

—

(3018418) pH of Serum or Plasma

2674

21255

1.36

36.65

3.5

4.1

7.40

1.89

446

4142

(40768797) Stomach Pathology biopsy report

1440

10277

1.47

36.64

1.2

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

795

4966

1.66

36.62

1.6

1.7

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

335

1606

2.13

35.66

1.3

1.4

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1529

11132

1.45

34.89

1.9

2.1

28.81

29.83

7.59

1429

10808

(3005322) IgE [Units/volume] in Serum or Plasma

757

4730

1.65

34.77

1.5

1.3

168.57

232.08

u/ml

1.96

697

4386

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

423

2241

1.93

34.11

1.5

1.8

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

323

1577

2.09

32.78

1.3

1.4

52.37

18.84

e6/l

0.46

271

1177

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

391

2046

1.95

32.70

1.3

20.72

38.56

u/ml

1.08

133

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

119

358

3.35

32.42

1.3

70.42

67.36

0.11

(3045414) Leukocytes [Presence] in Urine

557

3264

1.75

32.41

1.8

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

322

1579

2.08

32.31

1.3

1.4

2341.92

1151.22

e6/l

0.29

282

1256

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

311

1509

2.10

32.09

1.3

5.25

2.82

u/ml

0.28

112

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

157

562

2.82

31.74

1.1

41.95

41.05

mg/l

0.07

123

469

(3026389) Candida sp identified in Specimen by Organism specific culture

231

1012

2.31

30.71

1.5

1.3

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

152

545

2.82

30.65

1.1

286.48

263.39

mg/l

0.32

132

482

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

358

1878

1.94

29.73

1.3

5.95

5.87

u/ml

0.01

290

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

501

2920

1.76

29.68

1.1

7.74

1.97

u/ml

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

5798

52199

1.29

29.56

3.1

3.0

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

355

1861

1.94

29.54

1.3

3.09

5.04

u/ml

0.49

181

(3005719) IgG [Mass/volume] in Serum or Plasma

853

5710

1.54

29.14

2.7

2.6

10.05

10.63

g/l

4.20

769

5249

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1241

8972

1.44

28.95

4.9

4.2

31.33

32.02

1.44

917

6280

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

144

519

2.80

28.78

1.0

1.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

663

4198

1.62

28.75

3.4

3.3

5.18

5.14

kpa

0.69

628

3987

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

638

4005

1.64

28.64

3.3

3.2

1.82

1.69

mmol/l

0.46

484

2989

(3019225) pH of Specimen

990

6867

1.49

28.56

4.1

—

(3017704) Immunofixation for Urine

110

342

3.24

28.47

1.5

1.6

—

(3022621) pH of Urine by Test strip

720

4677

1.58

28.05

2.8

2.6

—

(3009343) pH of Capillary blood

653

4145

1.62

28.02

3.3

7.42

0.42

527

(3019897) Erythrocyte distribution width [Ratio] by Automated count

256

1215

2.14

28.02

3.1

2.5

13.32

13.16

1.83

256

1192

(3003338) MCHC [Mass/volume]

7359

68685

1.33

26.96

20.3

16.2

334.11

332.88

g/l

26.86

7327

68233

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

163

647

2.55

26.96

1.0

1.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

515

3111

1.69

26.80

3.7

3.5

25.61

25.25

mmol/l

1.49

477

3015

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

532

3249

1.68

26.57

2.0

1.9

40.38

39.75

u/l

0.32

473

2901

(3004119) Hemoglobin [Mass/volume] in Venous blood

637

4072

1.61

26.53

3.7

3.4

131.76

130.33

g/l

0.88

608

3980

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

399

2253

1.81

26.33

3.5

2.6

—

(3000494) Fungus identified in Specimen by Culture

1214

8900

1.42

26.03

1.6

1.4

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1466

11100

1.38

25.98

2.3

2.5

13.71

13.57

umol/l

0.28

1357

10410

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

764

5122

1.54

25.82

3.1

3.9

76.74

91.04

ng/l

4.07

672

4453

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

191

832

2.32

25.79

1.7

1.6

55.67

57.50

0.24

119

531

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

226

1064

2.15

25.28

1.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

8002

75861

1.37

24.64

4.3

3.8

1.42

1.31

mmol/l

25.30

7458

70258

(3020630) Protein [Mass/volume] in Serum or Plasma

815

5605

1.50

24.37

2.4

2.5

67.33

66.65

g/l

1.91

733

5163

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1356

10243

1.38

24.24

2.3

2.5

2.44

2.34

g/l

8.72

1247

9544

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

120

431

2.81

24.21

1.6

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

200

915

2.21

24.06

1.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1786

14088

1.33

24.03

1.6

1.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

247

1230

2.04

23.84

1.5

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

116

415

2.82

23.59

1.8

1.4

5.42

6.32

u/l

0.91

354

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

233

1141

2.07

23.54

1.2

1.3

—

(3023419) Bacteria identified in Sputum by Culture

212

1005

2.14

23.33

2.8

2.4

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

441

2673

1.68

22.66

2.1

2.0

1.73

2.03

ug/l

0.19

374

2392

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

108

381

2.86

22.56

1.1

1.13

1.07

u/l

0.39

174

(3020191) Ethanol [Moles/volume] in Serum or Plasma

153

642

2.41

22.54

1.8

1.4

1.36

1.38

promille

0.07

129

489

(3004588) Protein electrophoresis panel - Serum or Plasma

679

4573

1.52

22.40

2.3

2.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

194

907

2.16

22.14

1.3

71.10

60.50

u/ml

—

(3037756) Immunofixation for Serum or Plasma

261

1361

1.94

22.13

1.6

1.7

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2922

24811

1.26

21.83

4.8

4.4

2.35

2.82

ug/l

0.47

2691

22526

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

198

940

2.13

21.74

6.6

6.3

11.52

11.32

mg/l

0.26

182

872

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

285

1545

1.87

21.49

1.2

1.3

64.19

41.20

u/ml

1.02

156

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1356

10424

1.35

21.47

1.9

1.8

1.51

1.43

3.74

1191

9235

(3022313) Gas panel - Capillary blood

480

3023

1.62

21.22

3.5

3.3

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

105

379

2.79

21.05

1.3

1.4

1.30

1.24

nmol/l

0.22

293

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1256

9572

1.36

21.01

2.3

2.6

23.07

23.46

0.36

909

8252

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

169

764

2.23

20.98

1.6

1.5

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

169

764

2.23

20.98

1.6

1.5

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1160

8744

1.37

20.78

2.4

2.8

6.32

8.62

umol/l

5.13

984

7625

(3000475) Leukocytes [#/volume] in Synovial fluid

301

1680

1.82

20.69

1.7

1.6

11057.54

15086.80

e6/l

0.84

232

1197

(3045424) Erythrocytes [Presence] in Urine

240

1245

1.95

20.68

1.5

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

133

545

2.46

20.67

1.2

1.3

1.86

2.00

mmol/l

0.84

122

514

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

176

814

2.18

20.67

2.1

2.0

26.85

23.05

mg/l

0.36

218

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

428

2640

1.65

20.57

3.7

3.4

24.93

24.84

mmol/l

0.29

400

2423

(3009445) Proteinase 3 Ab [Units/volume] in Serum

490

3129

1.60

20.46

1.3

1.6

14.32

13.79

u/ml

—

(3014051) Protein [Presence] in Urine by Test strip

324

1855

1.77

20.45

2.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

353

2073

1.73

20.39

1.5

1.4

273.58

276.04

ug/g

0.08

200

1171

(3023520) Reticulocytes [#/volume] in Blood

784

5542

1.45

20.29

2.4

2.6

69.01

70.64

e9/l

0.58

648

4133

(1761482) Bacteria [#/volume] in Urine by Culture

296

1658

1.81

20.11

4.3

4.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

121

485

2.51

19.73

1.2

1.1

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

2844

24317

1.24

19.44

2.8

3.5

2.35

mmol/l

1.76

2483

21617

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

326

1899

1.74

19.39

1.5

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

686

4771

1.47

19.30

2.9

3.5

4.50

4.51

pmol/l

0.07

611

4256

(3007164) IgA [Mass/volume] in Serum or Plasma

1798

14584

1.29

19.17

1.5

1.4

2.34

2.43

g/l

1.46

1113

9184

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

463

2966

1.59

19.08

2.1

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

218

1132

1.95

18.77

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

218

1132

1.95

18.77

1.8

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

338

2.74

17.90

1.5

1.6

63.63

12.28

nmol/l

0.43

272

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

290

1678

1.75

17.69

1.8

1.7

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1481

11842

1.30

17.46

3.1

3.5

0.82

mmol/l

0.04

1380

11174

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1186

9210

1.33

17.28

5.1

6.0

1.04

1.03

mmol/l

0.67

1100

8625

(3025941) Bacteria identified in Stool by Culture

615

4278

1.47

17.27

1.3

1.2

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

383

2406

1.62

17.14

2.0

2.4

274.83

589.96

ug/l

2.41

363

2263

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

162

3.53

17.14

1.4

1.2

33.78

38.61

0.39

114

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

282

1634

1.75

17.13

1.9

1.7

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

254

1430

1.80

17.03

1.8

1.7

—

(3004616) Nuclear Ab [Presence] in Serum

173

867

2.01

16.54

1.3

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

246

1390

1.79

16.31

1.2

48.00

183.70

titre

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

181

927

1.97

16.28

1.4

1.5

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

321

2.69

16.27

2.2

81.46

157.78

umol/l

2.39

163

(3044927) Protein electrophoresis panel - Urine

136

626

2.19

16.26

1.2

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

351

2188

1.63

16.22

1.4

1.3

10.29

10.35

u/l

0.03

294

1821

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

355

2220

1.62

16.20

1.6

1.7

0.24

g/l

0.09

329

2105

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

364

2291

1.61

16.18

1.6

1.21

1.19

g/l

0.66

338

2182

(3026782) Osmolality of Urine

1737

14299

1.26

16.08

3.0

2.8

531.30

545.87

mosm/kgh2o

1.86

1507

12257

(3023511) Choriogonadotropin [Units/volume] in Urine

222

1227

1.83

15.84

1.4

1.3

—

(3022145) Colonoscopy Study observation

1105

8599

1.32

15.79

1.3

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

384

2473

1.58

15.51

2.2

7450.36

4524.01

u/l

0.68

114

967

(3010144) Erythrocytes [#/volume] in Synovial fluid

132

616

2.16

15.28

1.4

1.3

60514.70

94757.49

e6/l

0.26

435

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

175

907

1.95

15.24

1.4

1.5

—

(3027945) Reticulocytes/100 erythrocytes in Blood

973

7480

1.34

15.10

2.3

2.5

1.73

1.79

0.89

860

6651

(3011288) Drugs identified in Urine by Screen method

305

1872

1.65

15.02

3.4

3.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

138

663

2.10

14.84

1.3

1.6

—

(3012544) pH of Venous blood

854

6457

1.35

14.80

3.6

3.9

7.39

7.37

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

174

910

1.93

14.77

1.4

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

173

908

1.92

14.54

1.4

1.5

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

948

7316

1.33

14.30

3.7

3.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

172

914

1.90

13.94

1.4

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

172

914

1.90

13.94

1.4

1.5

—

(3052592) Norovirus Ag [Presence] in Stool

126

3.58

13.90

1.2

1.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

215

1227

1.77

13.85

1.1

1.2

—

(3044941) Cell count panel - Synovial fluid

195

1085

1.81

13.68

1.5

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

674

4981

1.38

13.47

1.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1018

8002

1.31

13.43

3.7

4.5

235.90

239.56

u/l

0.39

959

7590

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

561

4022

1.42

13.40

1.5

—

(3038515) Glucose [Moles/volume] in Venous blood

222

1300

1.72

13.09

3.5

3.1

7.36

mmol/l

0.00

217

1269

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2295

19876

1.20

12.71

4.5

3.8

21.58

21.75

0.20

945

9016

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

196

2.92

12.65

5.3

7.5

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

416

2869

1.47

12.25

4.3

3.9

48.73

49.40

0.21

410

2833

(3038026) Centromere Ab [Units/volume] in Serum

115

558

2.07

12.13

1.2

73.10

37.09

u/ml

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

138

3.27

12.13

5.6

7.6

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

186

2.91

11.97

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

220

1320

1.68

11.90

1.7

1.6

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

266

2.57

11.84

1.0

1.1

221.15

631.58

ng/l

0.56

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

349

2342

1.51

11.77

1.6

13.67

0.22

iu/ml

0.49

515

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

109

530

2.07

11.46

1.4

1.3

1.03

1.93

u/ml

0.90

298

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

182

1052

1.74

11.30

1.2

1.3

0.56

2.29

nmol/l

0.85

175

1016

(3038071) Oxygen [Partial pressure] in Mixed venous blood

176

2.91

11.29

5.1

7.8

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

111

549

2.03

11.16

1.2

96.13

39.23

u/ml

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

108

530

2.05

11.10

1.2

1.57

5.22

u/ml

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

942

7512

1.28

11.06

2.1

1.9

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

799

6239

1.31

11.03

2.5

2.2

12.40

13.20

nmol/l

2.19

712

5678

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

690

5290

1.33

10.86

1.2

123.29

154.43

iu/ml

1.49

276

2031

(3030981) Hyaline casts [#/volume] in Urine by Automated count

498

3637

1.39

10.72

2.7

2.6

0.26

0.28

e6/l

0.17

480

3533

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

165

943

1.76

10.68

1.3

321.34

452.26

pmol/l

0.61

147

812

(3006576) Bicarbonate [Moles/volume] in Blood

246

2.53

10.53

5.2

7.2

25.08

25.17

mmol/l

0.07

227

(3004451) EKG impression Narrative

320

2.32

10.43

1.3

—

(40760888) Immunoglobulin light chains.free panel - Serum

246

1573

1.58

10.37

3.0

3.3

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

192

1156

1.67

10.32

1.3

7.21

mmol/l

0.01

168

1035

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

281

1859

1.53

10.19

2.0

1.9

194.91

201.40

pmol/l

0.48

263

1774

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

178

1054

1.70

10.18

1.2

1.3

0.25

nmol/l

0.01

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

123

652

1.90

10.18

2.5

2.8

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1029

8378

1.26

10.15

2.1

2.0

—

(3021788) Differential panel - Synovial fluid

210

1302

1.63

10.07

1.7

1.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

240

1542

1.57

9.93

1.9

2.1

132.20

130.63

g/l

0.43

192

1092

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

358

2501

1.45

9.92

1.5

1.6

263.85

318.84

titre

0.10

116

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

192

1172

1.65

9.81

1.4

1.3

26.30

30.57

u/l

1.03

149

971

(3000850) Epithelial cells [#/volume] in Urine

1742

15024

1.20

9.74

2.7

2.5

5.72

5.52

e6/l

0.23

1563

13426

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

370

2617

1.43

9.60

2.5

2.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

522

3913

1.35

9.57

1.4

1.3

30.35

31.19

iu/l

0.22

473

3399

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

370

2622

1.43

9.50

2.5

2.2

7.30

7.33

g/l

0.16

325

2393

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

369

2618

1.43

9.42

2.5

2.2

3.48

3.69

g/l

2.76

324

2391

(4146454) Self-monitoring of blood glucose

126

693

1.83

9.33

3.0

2.6

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

478

3550

1.37

9.31

1.8

—

(3011985) Renin [Units/volume] in Plasma

169

1013

1.68

9.28

1.3

1.5

51.75

59.37

mu/l

0.30

153

906

(3024980) IgG subclass 4 [Mass/volume] in Serum

202

1267

1.61

9.28

1.5

0.68

0.75

g/l

0.40

115

961

(3028026) IgM [Mass/volume] in Serum or Plasma

588

4508

1.32

9.27

2.0

1.8

1.38

1.32

g/l

0.17

539

4139

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

131

732

1.80

9.22

1.9

1.8

—

(3002032) Base excess in Venous blood by calculation

779

6207

1.28

9.19

3.5

3.9

2.16

1.89

mmol/l

1.47

662

5313

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

316

2190

1.46

9.16

1.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

127

705

1.81

9.13

3.1

4.9

8.23

7.11

mmol/l

0.50

106

591

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

346

2442

1.43

9.10

2.5

2.2

9.66

10.25

g/l

1.92

298

2203

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

153

2.82

9.08

2.2

2.6

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

335

2.19

9.00

1.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1092

9067

1.23

8.98

1.5

1.6

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

362

2585

1.42

8.93

2.0

1.7

38.91

40.59

nmol/l

0.82

351

2522

(3025577) Chromium [Mass/volume] in Blood

382

2.10

8.93

2.4

2.0

2.75

2.39

ug/l

0.21

329

(4062490) Immunoglobulin typing, IgG

136

777

1.76

8.90

1.5

1.3

—

(40767503) Oxygen content in Capillary blood by calculation

228

1490

1.54

8.80

2.4

2.5

16.51

16.47

0.05

124

738

(3027135) IgG subclass 1 [Mass/volume] in Serum

136

781

1.75

8.75

1.5

1.3

6.81

6.82

g/l

0.01

538

(3024139) IgG subclass 3 [Mass/volume] in Serum

136

781

1.75

8.75

1.5

1.3

0.38

0.41

g/l

0.45

537

(3028192) IgG subclass 2 [Mass/volume] in Serum

136

782

1.75

8.71

1.5

1.3

3.08

3.01

g/l

0.15

538

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

502

1.94

8.69

2.4

2.8

0.22

0.24

e9/l

0.47

435

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1242

14616

0.83

8.64

2.9

2.8

0.66

0.73

ug/l

3.06

771

9148

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1055

8763

1.23

8.64

6.6

6.3

—

(3020491) Glucose [Moles/volume] in Blood

519

1.92

8.54

2.1

1.9

6.48

6.58

mmol/l

0.18

368

(3025018) Bordetella pertussis Ab [Titer] in Serum

416

2.03

8.53

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

294

2041

1.45

8.48

1.1

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

579

4494

1.31

8.37

1.9

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

104

560

1.87

8.29

1.6

2.0

17.83

18.14

nmol/l

0.14

534

(3021447) Carbon dioxide [Partial pressure] in Venous blood

771

6215

1.26

8.27

3.6

3.9

5.83

kpa

0.03

744

6041

(3035637) Corticotropin [Mass/volume] in Plasma

154

931

1.67

8.24

1.3

1.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

131

759

1.74

8.20

2.3

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

134

2.84

8.19

1.2

1.1

0.51

0.68

umol/24h

2.75

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

406

2.00

7.98

1.1

0.16

9.60

nmol/l

1.59

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

3.84

7.95

1.2

1.50

1.67

umol/24h

0.57

(3006245) CD3-CD19+ cells/100 cells in Blood

294

2.18

7.92

2.2

2.0

7.82

9.58

1.08

280

(3034860) Kappa light chains.free [Mass/volume] in Serum

297

2100

1.43

7.79

3.1

3.2

37.35

82.24

mg/l

0.99

236

1692

(3017181) Myelocytes/100 leukocytes in Blood

772

6270

1.25

7.77

3.3

4.3

0.87

0.93

0.28

291

2132

(3029937) Albumin [Presence] in Urine by Test strip

2171

19380

1.16

7.74

4.6

3.8

0.00

estimate

0.22

696

6596

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

290

2048

1.43

7.67

3.0

3.2

1.38

2.26

ratio

0.73

160

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

266

2.23

7.66

1.1

1.2

0.31

0.30

g/l

0.25

212

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

3.19

7.64

1.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

296

2100

1.42

7.63

3.1

3.2

30.78

44.47

mg/l

2.03

233

1696

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

420

1.96

7.62

1.3

1.5

—

(3003181) Sodium [Moles/volume] in Urine

179

1147

1.57

7.60

1.4

62.87

63.41

mmol/l

0.06

151

916

(3037121) Protein [Mass/volume] in Urine

330

2391

1.39

7.55

3.1

3.2

0.40

0.30

g/l

0.62

114

1080

(1001926) Buprenorphine [Presence] in Urine by Screen method

310

2224

1.41

7.51

2.9

2.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

271

1899

1.44

7.49

1.2

1.3

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

595

0.27

7.45

28.2

18.3

1508.69

3063.30

nmol/l

0.48

573

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

579

0.26

7.45

24.5

12.6

868.27

868.36

nmol/l

0.00

549

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

289

2.15

7.43

2.2

2.0

29.96

28.55

0.31

278

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

153

950

1.62

7.42

1.2

1.3

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

356

2620

1.37

7.41

1.6

1.7

254.63

299.69

mu/l

3.54

323

2372

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

129

769

1.69

7.33

1.2

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

392

1.97

7.30

2.2

1.9

4.85

3.17

ug/l

0.52

355

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

519

1.84

7.29

2.4

2.7

564.73

521.64

e6/l

0.34

439

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

272

2.18

7.27

2.6

2.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

318

2.08

7.27

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

132

2.73

7.26

1.6

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

156

980

1.60

7.22

1.4

1.5

—

(3003694) ABO and Rh group [Type] in Blood

2432

21978

1.14

7.20

1.4

—

(3002079) Sodium [Moles/time] in 24 hour Urine

353

2.02

7.20

1.1

1.2

167.73

163.82

mmol/24h

0.14

353

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

429

1.92

7.19

1.3

1.5

—

(3003327) Ova and parasites identified in Stool by Light microscopy

340

2503

1.37

7.08

1.6

1.7

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

291

2092

1.40

7.00

2.3

2.0

10.62

11.12

mg/l

0.57

271

1949

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

449

1.88

6.92

2.5

2.9

41.26

41.01

0.04

242

(21494755) Public health laboratory ask at order entry panel

782

9416

0.82

6.81

1.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1908

17013

1.15

6.80

4.0

3.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

114

674

1.70

6.72

2.0

1.9

—

(3020961) Endomysium IgA Ab [Titer] in Serum

449

3480

1.30

6.62

1.1

215.45

225.72

titre

0.03

(3021589) Normoblasts [#/volume] in Blood

3152

34031

0.89

6.54

11.2

9.2

0.00

e9/l

2.19

2672

27782

(3025159) Blasts/100 leukocytes in Blood

694

5681

1.24

6.53

3.4

4.3

0.35

0.39

0.06

212

1557

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

7275

74861

0.88

6.50

13.8

12.0

84.44

83.53

ml/min/173m2

3.47

6083

61889

(3010421) pH of Blood

265

1902

1.40

6.46

4.5

4.1

7.42

0.63

240

1732

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

213

1470

1.46

6.44

1.9

0.91

0.82

nmol/l

1.05

185

1258

(3034891) Synovial lining cells/100 cells in Synovial fluid

334

1.98

6.42

1.7

1.5

2.85

3.76

0.18

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

136

855

1.60

6.34

1.7

1.6

—

(3000764) Benzodiazepines [Presence] in Urine

382

2917

1.32

6.29

2.6

2.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

256

2.12

6.26

1.1

96.46

88.90

1.67

123

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

555

1.74

6.17

2.0

2.1

—

(3012501) Base excess in Blood by calculation

231

1633

1.43

6.16

4.6

4.1

2.51

2.49

mmol/l

0.05

169

1107

(3019420) Tryptase [Mass/volume] in Serum or Plasma

410

1.86

6.14

1.6

8.05

8.10

ug/l

0.01

369

(3036670) Protein [Mass/volume] in Synovial fluid

181

2.33

6.13

1.2

1.3

37.85

39.23

g/l

0.23

101

(3024869) Neuronal Ab [Presence] in Serum

127

2.60

6.11

1.0

1.1

—

(3049717) Cytology report of Urine Cyto stain

337

2541

1.34

6.07

2.6

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

163

1081

1.52

6.02

1.1

1.48

1.51

g/l

0.49

143

986

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

3.59

6.02

5.7

4.9

—

(3016879) Cocaine [Presence] in Urine

356

2711

1.33

6.00

2.6

2.2

—

(3006270) Folate [Moles/volume] in Blood

583

1.71

5.97

1.2

1.1

332.46

383.04

nmol/l

1.97

502

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

196

2.25

5.96

1.2

152.55

112.31

nmol/l

0.82

147

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

153

2.42

5.92

1.9

13.36

17.60

umol/l

1.64

153

(3028300) Cannabinoids [Presence] in Urine

382

2946

1.31

5.88

2.6

2.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.11

5.87

2.2

2.0

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

388

1.86

5.85

1.3

1.2

246.22

403.58

u/l

1.16

359

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

432

1.81

5.82

1.4

1.5

21.42

21.80

u/ml

0.02

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

494

3947

1.27

5.78

1.8

1.6

—

(3021901) Oxygen saturation in Capillary blood

175

1192

1.48

5.71

2.4

2.8

—

(4035726) Immunohistochemistry procedure

572

6983

0.81

5.70

1.3

1.4

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

465

1.77

5.67

1.1

4.57

8.96

iu/ml

1.37

127

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

364

1.87

5.66

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

163

2.34

5.63

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

163

2.34

5.63

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

163

2.34

5.63

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

163

2.34

5.63

1.1

—

(1616796) Gas panel - Central venous blood

218

1552

1.41

5.63

3.7

—

(3002582) Erythrocytes [#/volume] in Urine

2409

22060

1.12

5.55

3.5

3.1

41.60

82.76

e6/l

2.94

1933

16692

(4034850) Laboratory test

168

2431

0.69

5.55

9.3

8.1

—

(3028707) Methadone [Presence] in Urine by Screen method

176

1208

1.47

5.54

3.9

3.0

—

(3011412) CD3 cells [#/volume] in Blood

118

743

1.60

5.52

2.2

2.5

1.32

1.19

e9/l

0.94

107

669

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

326

2483

1.32

5.51

2.6

2.2

2.68

2.94

g/l

5.02

281

2257

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

368

1.85

5.48

1.1

5.33

13.06

u/ml

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

250

2.05

5.47

1.1

1.2

104.38

89.14

2.81

121

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

257

2.03

5.46

1.1

1.2

115.17

105.92

0.92

235

(3002179) Metamyelocytes/100 leukocytes in Blood

688

5742

1.21

5.40

3.0

4.1

0.75

0.66

0.31

256

1857

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

363

1.85

5.39

1.4

1.9

131.22

147.35

1.14

341

(3027008) Opiates [Presence] in Urine

377

2940

1.29

5.38

2.6

2.0

—

(3023183) Ammonium ion [Moles/volume] in Plasma

217

1557

1.40

5.38

2.3

2.9

28.58

35.10

umol/l

6.02

196

1414

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

5.61

5.36

1.4

1.0

0.03

0.05

mg/l

0.50

(40757373) Influenza virus identified in Isolate

124

2.50

5.35

1.3

1.7

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.09

5.33

2.3

2.0

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

196

1384

1.43

5.32

1.1

3.71

5.09

u/ml

0.69

690

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

722

8544

0.83

5.25

1.8

1.7

—

(36304419) Bacteria [Presence] in Urine

2167

19779

1.12

5.24

3.2

3.0

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

255

2.01

5.20

1.4

74.00

215.84

nmol/24h

1.38

255

(3008295) Osmolality of Serum or Plasma

113

716

1.59

5.18

1.4

276.87

279.53

mosm/kgh2o

0.66

574

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

480

1.71

5.12

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1408

12525

1.15

5.09

1.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1545

13830

1.14

5.09

1.8

—

(4094501) Cardiovascular stress test using bicycle ergometer

293

2226

1.33

5.08

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

251

2.00

5.06

1.4

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

335

1.86

5.06

1.4

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

335

1.86

5.06

1.4

1.5

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

100

619

1.62

5.05

1.7

1.5

27.78

30.76

0.31

369

(40761536) Microorganisms panel - Urine sediment

748

6344

1.19

4.96

4.7

3.7

—

(3033658) Prothrombin time (PT) actual/Normal

2151

19679

1.12

4.96

3.5

3.9

96.64

91.38

21.66

2071

19207

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

477

1.70

4.96

1.2

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

135

2.38

4.96

1.3

1.2

0.75

95.77

mg/l

1.20

101

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

253

1.98

4.95

2.3

2.0

68.29

60.46

ug/l

0.34

246

(3021440) Promyelocytes/100 leukocytes in Blood

705

5952

1.20

4.92

3.4

4.3

0.11

0.10

0.08

221

1821

(3027944) Amphetamines [Presence] in Urine

368

2897

1.28

4.91

2.0

—

(3036180) Methadone [Presence] in Urine

355

1.81

4.82

2.0

2.3

—

(3000492) Spirometry study

934

8096

1.17

4.79

1.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

364

2876

1.28

4.73

1.7

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

383

3046

1.27

4.72

1.6

1.7

1.55

1.54

g/l

0.10

335

2616

(3004775) Volume in Urine collected for unspecified duration

518

1.65

4.61

2.1

2.2

602.05

649.77

0.56

362

(44813793) Dust mix specific IgE antibody measurement

518

1.65

4.61

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

473

1.68

4.58

1.2

1.1

1.05

1.06

ratio

0.12

163

(1175426) CD3 cells/100 lymphocytes in Blood

604

1.60

4.58

2.0

2.1

74.17

73.45

0.20

585

(4281824) Cell count and differential, peritoneal fluid

889

0.54

4.55

1.1

1.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

138

942

1.47

4.54

1.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1293

11524

1.14

4.53

1.5

1.6

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

224

1668

1.35

4.49

1.9

1.7

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

235

1.96

4.47

1.3

1.2

17.17

24.31

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

249

1887

1.33

4.44

1.7

1.9

4.28

4.34

iu/l

0.04

730

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

594

1.59

4.42

1.9

2.1

14.76

14.99

0.08

584

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

257

1.91

4.42

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

257

1.91

4.42

1.2

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

373

1.75

4.40

1.1

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

261

1995

1.32

4.39

1.4

10.66

13.94

iu/ml

—

(40768800) Prostate Pathology biopsy report

102

1546

0.66

4.36

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

159

1125

1.42

4.35

1.3

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

138

2.25

4.30

1.6

2.0

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

339

1.77

4.30

2.3

2.4

53.23

50.45

umol/l

0.21

295

(3034092) Cytoplasmic Ig cells/100 cells in Blood

2.53

4.28

5.7

7.6

—

(3028717) Thiamine [Mass/volume] in Blood

2.70

4.24

1.1

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

205

1521

1.36

4.23

1.1

1.06

1.92

u/ml

1.04

104

728

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

254

1.89

4.23

2.2

1.8

157573.33

15720.19

u/ml

—

(3022806) Fractional oxyhemoglobin in Capillary blood

134

926

1.45

4.18

2.0

1.8

90.14

89.77

0.34

134

912

(3030467) Casts [#/volume] in Urine by Automated count

2193

20256

1.11

4.16

3.3

3.0

0.35

0.43

e6/l

0.94

1749

15138

(3000034) Microalbumin [Mass/volume] in Urine

104

683

1.53

4.16

2.6

2.9

23.88

63.55

mg/l

1.60

495

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

130

895

1.46

4.14

1.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

593

5018

1.19

4.08

3.2

4.57

4.67

kpa

0.57

572

4856

(44816559) Phosphatidylethanol [Mass/volume] in Blood

204

1522

1.35

4.08

1.7

1.4

—

(3006462) Nitrate [Presence] in Urine

330

1.76

4.08

3.0

3.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

470

3891

1.22

4.07

1.0

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

2.53

3.95

1.6

1.3

1.85

1.80

mmol/l

0.01

(3009015) Lactate [Moles/volume] in Synovial fluid

2.82

3.95

1.2

1.3

6.43

5.71

mmol/l

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

159

1148

1.39

3.91

1.2

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

183

1352

1.36

3.91

1.9

4.90

5.23

mmol/24h

0.78

163

1203

(3008757) Leukocyte morphology finding [Identifier] in Blood

109

734

1.49

3.90

3.3

4.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

689

5933

1.17

3.88

3.5

3.9

1.23

mmol/l

0.68

599

5201

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.45

3.87

1.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

524

6202

0.84

3.86

2.0

2.5

70.77

68.03

ml/min/173m2

0.80

211

2368

(3051593) INR in Capillary blood by Coagulation assay

277

1.81

3.86

4.3

9.8

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

165

1203

1.38

3.84

1.9

1.8

—

(3042631) Mycobacterium sp identified in Specimen

131

920

1.43

3.79

2.6

2.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

250

1.84

3.78

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

179

1330

1.35

3.71

1.1

0.67

1.33

u/ml

1.65

540

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

123

858

1.44

3.70

1.2

1.1

—

1.86

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

325

2617

1.25

3.69

1.9

1.8

—

(3023410) Appearance of Cerebral spinal fluid

108

738

1.47

3.62

1.3

1.5

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

577

1.53

3.60

1.3

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

620

0.51

3.60

1.0

1.1

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

516

4370

1.19

3.56

6.8

7.5

25.08

24.75

mmol/l

1.44

511

4343

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

351

2863

1.23

3.56

2.2

2.0

—

(3014271) Vancomycin [Susceptibility]

285

1.76

3.54

2.7

2.9

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

103

701

1.47

3.53

3.1

3.7

57.28

56.35

0.18

598

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

230

2934

0.78

3.48

1.4

1.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

207

1.89

3.47

4.6

2.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

207

1.89

3.47

4.6

2.5

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

251

1.80

3.43

1.3

1.5

13.88

15.60

pmol/l

1.11

213

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

161

1194

1.35

3.41

1.1

11.90

13.35

au/ml

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

670

5821

1.16

3.40

2.3

2.2

6.26

8.14

ug/l

1.49

569

5143

(3016018) Differential panel - Cerebral spinal fluid

116

815

1.43

3.39

1.3

1.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

458

1.58

3.39

1.0

—

(3016750) Collection duration of Urine

381

1.63

3.36

2.0

2.1

493.02

497.47

min

0.12

294

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.92

3.29

2.3

1.6

53.00

41.56

umol/l

0.86

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

193

1479

1.31

3.29

1.3

1.6

—

(3019977) pH of Arterial blood

376

1.63

3.27

4.2

2.6

7.42

0.01

126

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

569

1.50

3.20

1.1

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

569

1.50

3.20

1.1

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

570

1.50

3.18

1.1

1.2

—

(3015183) Erythrocyte sedimentation rate

427

1.57

3.15

1.2

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

637

1.46

3.13

1.1

1.0

287.66

284.35

mg/l

0.19

573

(40759836) Histone Ab [Presence] in Serum by Immunoblot

565

1.49

3.10

1.1

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

565

1.49

3.10

1.1

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.29

3.09

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

566

1.49

3.08

1.1

1.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

526

1.51

3.07

1.9

1.6

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

269

1.71

3.03

1.8

1.9

6.55

9.67

mg/l

4.06

218

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

896

8012

1.13

3.02

1.4

—

(3040893) Potassium [Moles/volume] in Capillary blood

5.84

3.02

1.6

1.5

4.23

4.54

mmol/l

—

(3004809) Band form neutrophils/100 leukocytes in Blood

152

1142

1.34

3.01

2.8

3.5

1.06

1.61

1.68

140

1021

(3012494) Peanut IgE Ab [Units/volume] in Serum

197

1.83

2.96

1.1

0.82

1.81

u/ml

0.64

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

488

5665

0.85

2.92

1.4

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

6.67

2.86

1.8

1.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

179

1.85

2.81

1.1

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1377

0.72

2.81

1.4

1.5

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.40

2.79

1.0

1.1

—

(40768793) Breast Pathology biopsy report

131

1743

0.75

2.79

1.2

1.3

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

3.57

2.78

1.3

1.2

2.36

1.64

mg/l

—

(3002256) Pathology report gross observation

914

10132

0.89

2.77

1.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

129

1718

0.75

2.77

1.4

1.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

269

1.68

2.77

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

100

713

1.41

2.76

1.9

2.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

180

1.84

2.76

1.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

188

1.81

2.73

1.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

174

1.84

2.71

1.0

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

444

1.51

2.70

1.5

1.4

—

(40762814) Titanium [Mass/volume] in Blood

2.15

2.70

2.5

2.3

2.53

4.28

ug/l

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.28

2.67

1.0

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.93

2.61

1.2

1.0

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

162

1.85

2.61

1.5

1.6

0.50

0.39

ug/l

0.57

106

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

352

1.57

2.60

1.1

94.55

96.32

0.19

284

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1334

0.72

2.59

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

439

3784

1.17

2.55

1.4

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

121

1.99

2.54

1.5

1.2

2.14

1.78

mmol/l

0.51

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.38

2.45

1.1

1.0

—

(3018095) Leukocytes [#/volume] in Urine

2721

25882

1.07

2.44

3.9

3.5

74.96

86.26

e6/l

0.42

2073

18036

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.55

2.44

1.2

1.1

—

(3005033) Fetal Nuchal fold Thickness US

1329

0.73

2.42

1.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

171

1351

1.27

2.41

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

288

1.60

2.41

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

189

1.75

2.40

1.0

1.1

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

2.42

2.36

1.0

0.03

0.14

u/ml

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

590

0.61

2.35

1.1

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

106

787

1.35

2.35

1.7

1.6

—

(3048879) Bone marrow aspiration report

198

1.72

2.34

1.8

2.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

412

0.53

2.34

1.0

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

409

4721

0.86

2.34

1.6

1.7

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

155

1216

1.28

2.32

1.1

127.21

117.12

3.30

140

1103

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1194

12929

0.91

2.31

2.7

3.1

2.44

2.45

mmol/l

2.39

1035

11349

(3028433) Virus identified in Specimen by Culture

253

1.62

2.29

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

185

1.73

2.27

1.0

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

146

1141

1.28

2.27

1.1

2.20

3.71

u/ml

1.61

587

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.48

2.26

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

357

1.52

2.26

1.1

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

775

7001

1.12

2.25

2.1

2.3

0.23

0.22

g/l

3.36

698

6544

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

127

1.89

2.25

1.1

1.6

—

(3042517) Benzodiazepines panel - Urine

2.15

2.24

1.9

2.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

138

1075

1.29

2.21

3.0

2.9

0.80

0.82

nmol/l

0.27

102

807

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.50

2.18

1.0

1.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

3.34

2.18

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

165

1319

1.26

2.15

1.2

1.1

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

452

1.44

2.14

1.3

2.3

112.29

96.47

2.55

423

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

212

1.65

2.12

1.1

1.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

355

1.50

2.11

1.6

1.7

2.82

2.83

u/field

0.00

261

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

588

1.38

2.10

2.0

1.9

3.37

3.88

mg/l

0.40

558

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

380

1.48

2.09

1.3

84.00

61.14

titre

—

(3045716) Anion gap in Serum or Plasma

308

1.53

2.07

5.1

2.4

10.89

9.74

mmol/l

1.58

302

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

5.00

2.07

1.0

1.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

373

1.48

2.06

2.3

2.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

374

1.47

2.04

2.3

2.2

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

4.00

2.04

1.0

1.4

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

172

1393

1.24

2.02

2.3

3.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

105

801

1.31

1.99

1.1

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

740

0.69

1.95

2.7

3.7

32.26

44.65

u/ml

0.63

733

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

297

1.52

1.94

2.5

2.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

297

1.52

1.94

2.5

2.4

—

(3016038) Potassium [Moles/volume] in Urine

420

1.43

1.94

1.2

31.43

35.46

mmol/l

0.74

370

(3002619) Bacteria identified in Specimen by Culture

149

1.75

1.94

1.3

1.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1332

12447

1.08

1.92

2.9

2.7

1.20

1.12

e6/l

0.26

841

6931

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

147

1179

1.25

1.90

1.5

1.2

25.14

34.95

u/l

1.04

128

1025

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

128

1.80

1.89

1.5

114.00

125.34

ng/l

0.16

128

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

300

1.50

1.86

2.6

2.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

195

1617

1.21

1.85

2.1

2.2

118.26

104.10

ug/min

0.15

114

988

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

129

1.78

1.85

1.0

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.03

1.85

1.0

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

252

2140

1.18

1.84

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

213

1.60

1.84

2.1

2.0

136.15

240.00

e6/l

0.52

117

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

400

1.43

1.83

1.5

—

(3007566) Smooth muscle Ab [Titer] in Serum

264

2257

1.17

1.79

1.2

1.3

74.85

142.62

titre

1.50

221

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

199

1.61

1.79

1.2

1.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

252

2149

1.18

1.77

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

404

1.41

1.75

1.5

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

497

1.37

1.75

1.9

1.56

1.60

u/field

0.03

215

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

687

0.70

1.74

1.3

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1258

0.78

1.73

1.7

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

263

2256

1.17

1.73

2.9

2.3

1.02

0.86

g/l

0.30

215

1960

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

397

1.41

1.72

1.3

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

364

1.43

1.71

1.5

1.6

4634153.88

1110329.18

iu/ml

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

248

2119

1.17

1.71

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

140

1.72

1.71

1.2

1.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1064

0.76

1.71

1.4

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

371

0.59

1.70

1.5

1.8

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

240

2047

1.18

1.70

2.5

2.1

38.86

37.97

g/l

1.98

195

1816

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

159

1309

1.22

1.66

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

173

1.62

1.63

2.6

1.1

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

150

1.67

1.62

2.2

5.2

47.24

65.90

u/l

0.68

145

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

487

0.66

1.61

1.2

80.63

88.01

u/l

0.17

418

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

311

1.45

1.60

3.4

3.7

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

239

2776

0.86

1.58

1.4

—

(40768806) Pleura Pathology biopsy report

696

0.72

1.57

1.8

1.5

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

472

0.66

1.57

1.2

15.00

21.87

u/l

0.94

397

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

330

1.43

1.55

1.9

2.6

—

(3044009) aPTT.lupus sensitive (LA screen)

2.11

1.54

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

364

1.40

1.54

1.4

1.7

—

(3000093) Morphology [Interpretation] in Blood Narrative

631

1.30

1.53

1.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

1090

0.78

1.53

2.6

2.7

89.22

1144.48

u/ml

0.67

1075

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

562

1.32

1.52

1.6

1.5

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

1.52

0.0

1.1

—

(3007463) Buprenorphine [Presence] in Urine

2.86

1.50

2.5

9.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

668

7263

0.91

1.48

2.5

31.68

40.32

u/l

2.34

557

6269

(3048929) Epstein Barr virus Ab [Presence] in Serum

272

2372

1.15

1.48

1.3

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

147

1217

1.21

1.48

1.1

91.09

8642.44

iu/ml

0.56

281

(3029075) Extractable nuclear Ab panel - Serum

202

1.54

1.47

1.1

—

(40768443) Skin Pathology biopsy report

374

3333

1.13

1.47

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

163

1.60

1.45

1.0

1.1

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

3.13

1.44

4.4

6.9

0.51

0.23

mmol/l

—

(3024263) Appearance of Synovial fluid

378

1.38

1.43

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

141

1168

1.21

1.43

1.8

1.6

—

(3033799) Differential panel - Peritoneal fluid

252

0.55

1.41

1.4

1.8

—

(3035933) Granulocytes/100 leukocytes in Blood

237

1.48

1.41

1.6

—

(3020876) Protein [Mass/time] in 24 hour Urine

782

1.26

1.41

2.6

2.5

1.52

1.34

g/24h

0.19

399

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

363

1.38

1.39

1.1

186.31

165.17

iu/ml

0.33

358

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.89

1.38

1.1

1.0

—

(3012441) Differential panel - Pleural fluid

656

0.73

1.38

1.7

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

132

1589

0.83

1.37

1.3

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

110

893

1.23

1.36

1.2

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.61

1.36

1.0

—

(40757494) Bilirubin.total [Moles/volume] in Blood

365

1.37

1.36

2.0

2.5

24.08

39.01

umol/l

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

2.94

1.36

1.0

1.1

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

207

1.50

1.34

1.6

197.25

98.32

au/ml

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

332

1.39

1.34

1.2

1.1

3.57

3.64

iu/ml

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

845

0.77

1.34

1.4

5.60

3.94

ug/l

0.45

727

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

654

1.27

1.33

3.3

3.8

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1233

11657

1.07

1.33

3.1

2.8

3.34

2.53

e6/l

1.39

739

6170

(3039443) Prostate specific Ag panel - Serum or Plasma

155

1831

0.84

1.32

1.6

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

144

1.60

1.31

2.0

2.2

7.37

8.27

mmol/l

0.38

(3017817) Protein [Mass] in Urine collected for unspecified duration

647

1.27

1.31

2.3

2.4

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.81

1.31

1.0

1.1

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

603

1.28

1.31

2.0

1.9

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

603

1.28

1.31

2.0

1.9

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

603

1.28

1.31

2.0

1.9

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

416

0.67

1.30

1.4

1.5

—

(40768795) Lymph node Pathology biopsy report

784

0.76

1.29

1.2

—

(1761868) Lipid panel - Serum or Plasma

2996

30890

0.96

1.28

3.1

2.7

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

170

1.53

1.25

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

134

1594

0.84

1.25

1.3

1.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

572

1.28

1.25

1.1

—

(3034770) Mitochondria Ab [Titer] in Serum

255

2247

1.14

1.24

1.2

1.3

991.25

913.82

titre

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.40

1.24

1.3

1.2

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.40

1.24

1.3

1.2

476.20

424.58

nmol/l

—

(3051651) Icteric interference index of Serum or Plasma

457

0.70

1.23

4.0

3.6

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

1.97

1.22

1.0

0.03

0.02

u/ml

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.72

1.21

1.0

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.80

1.20

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

101

1.68

1.19

1.0

0.04

1.41

u/ml

0.91

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

101

1.68

1.19

2.2

2.8

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

755

1.23

1.19

4.1

4.9

259.98

76.25

u/ml

0.63

225

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

138

1166

1.19

1.18

1.3

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

489

1.29

1.17

1.0

310.84

315.07

ng/l

0.05

345

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

1.93

1.16

1.0

0.02

0.05

u/ml

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.05

1.15

1.5

1.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

223

2531

0.88

1.15

1.3

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

1.15

0.0

1.2

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

1.14

0.0

1.2

—

30.61

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

369

1.33

1.13

1.1

1317.42

1490.91

miu/ml

0.51

369

(3010726) Horse dander IgE Ab [Units/volume] in Serum

149

1273

1.17

1.13

1.0

1.1

2.89

1.44

u/ml

0.60

606

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

183

1.48

1.12

1.4

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

1.90

1.12

1.1

1.0

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

132

1553

0.85

1.11

3.4

3.6

127.69

579.66

u/ml

1.79

120

1421

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

136

1596

0.85

1.11

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

136

1595

0.85

1.10

1.3

1.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

184

1602

1.15

1.10

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

173

1500

1.16

1.10

1.2

269.41

285.23

u/ml

0.20

116

970

(40761535) Cells panel - Urine sediment

606

5634

1.08

3.9

3.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

218

1.42

1.08

1.2

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

381

1.31

1.08

1.2

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

122

1030

1.19

1.08

1.0

1.1

4.31

3.34

u/ml

0.22

400

(3034274) Bile acid [Moles/volume] in Serum --fasting

820

1.21

1.07

2.2

1.9

6.44

7.36

umol/l

0.17

588

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

488

1.27

1.06

1.0

759.89

740.07

ng/l

0.14

332

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

105

1.62

1.05

1.0

0.00

0.36

u/ml

—

(3046861) Legionella sp Ag [Presence] in Urine

2.12

1.05

1.1

1.0

—

(3020779) Urea [Moles/volume] in Serum or Plasma

678

6342

1.07

1.04

7.1

7.7

9.12

9.26

mmol/l

0.23

644

6065

(3014133) Dog dander IgE Ab [Units/volume] in Serum

129

1099

1.18

1.04

1.0

1.1

3.40

3.04

u/ml

0.12

499

(37021550) Renin [Units/volume] in Plasma --upright

154

1.49

1.03

1.3

66.81

51.09

mu/l

0.12

120

(3019230) Fractional oxyhemoglobin in Venous blood

107

1271

0.84

1.03

2.9

61.99

65.05

0.79

107

1266

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

491

1.26

1.02

1.0

42.71

41.25

ng/l

0.09

340

(3008607) Semen analysis panel

1.92

1.02

1.2

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

1.89

1.01

1.0

0.01

1.13

u/ml

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

662

6199

1.07

1.00

6.3

7.5

1.32

1.34

mmol/l

0.22

651

6048

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

466

1.27

1.00

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

274

2467

1.11

0.99

1.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

674

0.79

0.99

1.5

33580.84

57199.39

e6/l

0.59

392

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

223

1.39

0.98

1.3

1.5

9.71

8.70

ug/l

0.51

223

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

184

1619

1.14

0.98

5.7

5.9

603.15

2514.85

iu/ml

0.97

231

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.63

0.97

1.0

1.1

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

1.85

0.96

1.0

1.3

—

18.47

—

(3045788) Cell count panel - Pleural fluid

581

0.77

0.95

1.6

1.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

270

2437

1.11

0.95

1.3

192.23

225.38

miu/ml

0.85

118

1120

(1002224) Polysomnography panel

347

3788

0.91

0.93

1.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

2.22

0.93

1.2

1.0

—

(3045142) Bone marrow Pathology biopsy report

821

0.81

0.92

1.4

1.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

755

0.81

0.92

1.6

1.5

2225.94

2371.37

e6/l

0.11

539

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.82

0.92

1.1

1.3

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

236

1.36

0.89

1.1

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

639

6007

1.07

0.89

1.3

1.4

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

810

7675

1.06

0.88

3.1

4.3

15.68

27.40

ug/l

0.66

636

6179

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.65

0.87

1.2

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.86

0.87

4.3

5.7

—

(3001556) Androgen free Index in Serum or Plasma

1.72

0.86

1.1

1.2

—

(3000012) Reticulocyte production index

112

963

1.16

0.85

1.7

2.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

230

1.35

0.84

2.8

3.6

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

480

0.77

0.84

1.1

1.3

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.78

0.84

1.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.78

0.84

7.9

4.8

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

137

1.46

0.83

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

137

1.46

0.83

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

137

1.46

0.83

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

734

1.19

0.83

1.4

1.3

153.72

181.20

pmol/l

0.89

734

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

129

1.47

0.83

1.4

1.8

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

129

1.47

0.83

1.2

1.4

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

121

1.49

0.82

1.1

1.0

—

(3019174) dRVVT (LA screen)

1.69

0.82

1.0

1.2

—

(3025130) Human papilloma virus identified in Specimen

1069

0.85

0.82

1.9

1.8

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

197

1.37

0.81

1.1

1.0

1.13

13.57

u/ml

8.32

121

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.70

0.80

1.0

1.2

—

(3024932) HLA-DR beta [Type]

283

0.71

0.80

1.2

1.1

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

188

0.64

0.79

1.4

1.1

68.42

63.91

u/ml

0.07

181

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.82

0.79

12.5

7.5

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.82

0.79

2.0

8.6

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

608

0.80

0.79

1.1

1.3

1.52

1.55

g/l

0.34

608

(3013293) Extractable nuclear Ab [Presence] in Serum

115

1.48

0.76

1.8

1.7

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

1.77

0.76

1.0

0.64

3.27

u/ml

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

238

2166

1.10

0.76

2.0

1.6

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

132

1.44

0.75

1.0

0.77

3.03

u/ml

0.56

111

(40768804) Tissue Pathology biopsy report

3132

31976

0.97

0.75

2.1

2.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.70

0.75

1.2

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.54

0.75

1.5

1.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

450

1.22

0.74

1.2

—

(40768446) Kidney Pathology biopsy report

324

0.74

1.5

1.6

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

497

1.21

0.72

1.7

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

125

1.44

0.72

1.4

1.5

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

207

0.68

0.72

1.1

1.4

9.79

12.66

g/l

—

157

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.61

0.72

1.0

1.2

5.00

15.14

u/l

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.61

0.72

1.0

1.9

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.55

0.71

1.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.62

0.71

1.0

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

264

1.29

0.71

1.1

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

136

1207

1.13

0.70

1.5

1.4

0.33

0.39

nmol/l

0.59

107

924

(3042733) HLA Ab [Presence] in Serum

286

0.73

0.69

3.6

5.1

—

(3024471) HLA-A [Type]

286

0.73

0.69

1.0

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

141

1258

1.12

0.67

1.3

1.2

5.78

3.98

u/ml

0.53

549

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

231

2518

0.92

0.67

1.7

2.1

97.32

92.16

3.46

222

2424

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.63

0.66

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.51

0.66

1.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

214

0.70

0.66

1.0

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

248

0.73

0.65

2.8

1.9

35261.30

15919.10

e6/l

—

123

(3003721) Smooth muscle Ab [Units/volume] in Serum

1.59

0.65

1.0

1.1

—

2.30

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

128

1142

1.12

0.63

4.1

5.4

343.04

368.81

umol/l

1.25

106

977

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

775

1.15

0.63

1.3

1.2

—

(3022689) Creatine [Moles/volume] in Urine

223

0.72

0.62

1.3

1.5

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

270

1.26

0.62

1.6

1.9

158.14

174.00

0.40

255

(3009677) Dengue virus Ab [Presence] in Serum

1.67

0.61

1.0

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.60

0.61

1.0

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

182

1.32

0.61

1.1

—

(3011648) Oxygen content in Venous blood

596

0.84

0.59

2.6

2.3

11.35

11.26

0.05

596

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

223

2058

1.09

0.58

2.6

3.0

1.54

1.49

mg/l

0.39

198

1909

(40761995) Spermatozoa Progressive [#/volume] in Semen

185

0.70

0.58

4.5

3.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

139

1254

1.11

0.58

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.71

0.57

1.0

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

484

1.18

0.56

1.0

0.35

1.68

u/ml

0.97

141

(3023420) DNA double strand Ab [Units/volume] in Serum

858

1.13

0.56

1.6

1.5

17.00

28.22

iu/ml

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

184

0.71

0.56

9.1

6.0

—

(3001729) Color of Synovial fluid

1.45

0.56

1.4

1.3

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.45

0.56

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

321

1.22

0.54

2.6

3.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

293

2746

1.07

0.52

2.4

3.7

502.50

2312.82

u/ml

1.03

239

2354

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

202

1868

1.08

0.52

2.7

2.2

0.00

g/l

0.79

181

1715

(3011325) HIV 1+2 Ab [Presence] in Serum

1.50

0.51

1.0

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

100

0.60

0.51

2.5

1.5

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

216

2005

1.08

0.51

2.6

2.1

0.03

0.02

g/l

0.14

194

1847

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

213

2294

0.93

0.51

2.0

2.6

3.55

3.62

g/l

0.32

194

2184

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

161

1477

1.09

0.50

1.4

1.5

150.16

113.43

u/ml

0.94

313

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

1.41

0.50

1.2

0.44

0.30

nmol/l

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

136

1239

1.10

0.49

2.8

2.7

329.55

1829.77

u/ml

1.31

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.52

0.48

1.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.52

0.48

1.0

1.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

175

1616

1.08

0.48

1.4

13.13

22.77

u/ml

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

308

1.20

0.47

2.1

1.8

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.49

0.47

1.0

1.1

—

(3024928) Oxygen saturation in Venous blood

163

1502

1.09

0.47

3.4

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

111

1.35

0.46

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

321

0.81

0.46

1.7

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

533

1.15

0.45

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

153

0.72

0.45

2.1

2.8

68.08

157.58

ng/l

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

386

1.17

0.43

1.2

—

(3043409) Potassium [Moles/volume] in Arterial blood

218

2042

1.07

0.43

4.0

4.3

3.84

3.88

mmol/l

0.66

213

2024

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

322

3054

1.06

0.43

1.7

6.01

3.96

mg/l

1.31

243

2196

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

338

0.83

0.41

1.4

2.8

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

141

1301

1.09

0.41

1.3

1.2

2.40

3.55

u/ml

0.83

428

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.43

0.41

1.8

2.3

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.41

0.0

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.41

0.0

1.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.41

0.0

2.2

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.41

0.0

1.1

—

3302.46

—

(40768441) Liver Pathology biopsy report

626

0.88

0.41

1.3

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

181

1939

0.93

0.41

1.5

1.4

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.40

0.0

6.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

305

1.18

0.40

2.6

2.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

186

1.24

0.40

1.5

1.3

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.40

0.0

1.0

—

11950.00

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

315

1.18

0.39

1.2

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

531

1.13

0.39

1.1

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

883

1.10

0.39

2.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

119

1094

1.09

0.39

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.39

0.0

2.1

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

187

1.23

0.38

1.3

59.54

53.32

0.26

157

(3008536) Aspergillus sp Ab [Presence] in Serum

151

1.26

0.38

2.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

153

1424

1.08

0.38

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

153

1424

1.08

0.38

1.3

—

(3020891) Body temperature

286

2718

1.05

0.37

5.0

4.8

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

131

1414

0.93

0.37

1.4

1.5

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.35

0.37

1.0

1.8

—

(3018405) Lactate [Moles/volume] in Arterial blood

252

2388

1.06

0.37

3.9

4.1

1.48

1.38

mmol/l

0.54

244

2352

(3001964) Herpes simplex virus Ag [Presence] in Specimen

216

1.20

0.36

1.6

1.5

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

289

0.83

0.36

2.7

3.2

6.41

7.67

mg/l

0.50

238

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

300

1.17

0.36

1.1

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

0.66

0.35

3.8

3.1

1.12

0.99

mg/l

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

0.66

0.35

1.0

1.3

—

(3020393) Adenovirus Ag [Presence] in Stool

0.62

0.35

1.0

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

219

2315

0.94

0.35

2.0

2.4

166.10

188.84

3.75

203

2197

(3005011) Chlamydia sp Ab [Titer] in Serum

124

0.73

0.35

1.9

1.6

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

198

1867

1.06

0.35

1.3

—

(3035880) pH of Pleural fluid

339

1.15

0.34

1.3

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

435

0.87

0.33

1.0

0.17

1.27

u/ml

0.73

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.28

0.32

1.0

1.1

9.31

8.17

mmol/l

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

877

1.08

0.31

1.7

2.2

33.06

32.91

0.13

871

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

559

0.89

0.31

1.2

1.1

—

(40765096) Chromosome analysis panel by Banding

208

0.82

0.31

1.4

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

715

0.91

0.30

1.0

1.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

179

1694

1.06

0.30

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

102

1.27

0.30

1.0

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

223

2340

0.95

0.29

3.0

3.2

0.37

0.34

u/ml

0.88

143

1323

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

170

1796

0.95

0.29

1.4

1.5

64.89

148.00

pmol/l

7.91

165

1751

(3022475) Manganese [Moles/volume] in Blood

1.23

0.29

1.1

1.3

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

260

1.15

0.28

1.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

159

1504

1.06

0.28

1.6

1.5

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

280

0.86

0.27

2.5

2.0

44365.63

863.49

e6/l

0.75

186

(43055514) Macroprolactin [Presence] in Serum or Plasma

177

1.19

0.27

1.1

1.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

171

1623

1.05

0.27

1.4

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

347

1.12

0.26

1.9

2.1

175.94

196.24

ug/min

0.07

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

104

1.25

0.26

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

212

2026

1.05

0.26

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.26

0.26

2.3

2.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

863

0.93

0.26

1.3

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

193

1842

1.05

0.25

2.7

2.2

0.00

g/l

-0.00

177

1712

(3050794) Legionella sp Ab [Presence] in Serum

1.23

0.25

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

511

1.10

0.25

5.8

6.5

—

(40758292) HTLV I+II Ab panel - Serum

151

1.19

0.25

1.6

1.4

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.20

0.25

1.2

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.20

0.25

1.0

1.1

—

(3000991) Gas panel - Venous blood

577

5912

0.97

0.24

7.3

9.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

527

0.91

0.23

1.7

1.6

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

920

1.07

0.23

1.1

1.0

0.04

0.67

u/ml

1.96

245

(3035320) C reactive protein [Mass/volume] in Body fluid

524

1.09

0.23

2.7

2.3

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.28

0.23

1.0

1.6

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

515

1.09

0.22

1.5

1.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

267

1.12

0.21

1.1

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.21

0.0

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.21

0.0

1.1

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.21

0.0

2.5

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.21

0.0

1.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

915

1.06

0.21

1.6

1.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

684

6706

1.02

0.20

1.6

1.7

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.20

0.0

1.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

902

0.94

0.20

2.5

—

(3047189) Immunofixation for 24 hour Urine

333

0.90

0.19

2.2

1.7

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

165

1.15

0.19

1.2

1.7

2.20

2.07

ug/l

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.23

0.18

1.0

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

185

0.86

0.18

1.6

1.8

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

147

1.16

0.18

1.0

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

321

0.90

0.18

1.2

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

321

0.90

0.18

1.2

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

143

1372

1.04

0.18

1.2

1.1

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

1.17

0.17

1.0

—

13.19

—

(3020650) Glucose [Presence] in Urine

234

1.11

0.16

1.3

1.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

709

1.06

0.16

1.3

1.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

524

1.07

0.16

1.2

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

389

3805

1.02

0.16

8.2

10.1

24.57

24.29

mmol/l

1.35

381

3704

(3010015) Selenium [Moles/volume] in Serum or Plasma

1.11

0.16

1.3

2.1

1.24

1.36

umol/l

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

130

0.85

0.16

3.2

5.4

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

111

1.17

0.15

1.0

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

235

1.11

0.15

2.6

3.0

27.34

28.64

umol/l

0.24

165

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

119

0.84

0.15

1.0

1.2

—

(21494434) Karyotype in Bone marrow

604

1.06

0.15

1.3

1.2

—

(3017509) Phencyclidine [Presence] in Urine

1.11

0.15

1.2

1.6

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

207

1.11

0.15

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

635

0.94

0.14

1.1

1.3

255.71

242.46

titre

—

118

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

900

1.04

0.14

3.2

3.3

3.36

11.80

nmol/l

0.78

881

(3051611) Lipemic interference index of Serum or Plasma

735

0.95

0.13

3.4

3.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

304

0.92

0.13

1.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

142

1377

1.03

0.12

1.2

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

223

2180

1.02

0.11

3.1

3.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

199

0.90

0.11

1.5

1.6

—

(3044242) Glucose [Moles/volume] in Arterial blood

332

0.93

0.11

3.0

2.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

134

1.12

0.10

1.1

—

(3051339) Copper [Moles/volume] in Blood

1.14

0.10

1.0

1.1

16.50

16.38

umol/l

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.14

0.10

1.2

1.1

—

(3044007) Cell count panel - Peritoneal fluid

228

0.92

0.10

2.9

2.0

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

809

0.96

0.10

1.2

52.16

59.77

u/l

0.96

718

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.11

0.09

1.0

1.2

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.07

0.08

1.0

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.03

0.08

1.0

1.1

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

445

4502

0.99

0.08

8.3

9.7

1.47

1.37

1.07

439

4475

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

0.78

0.08

3.2

2.4

0.80

0.55

u/field

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

256

0.94

0.07

1.4

2.0

—

(3000285) Sodium [Moles/volume] in Blood

0.80

0.07

1.2

1.1

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

444

4487

0.99

0.07

8.4

9.8

0.73

0.66

2.76

438

4459

(3032868) Hemoglobin electrophoresis panel in Blood

0.87

0.07

1.6

1.4

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.83

0.07

1.1

1.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

155

1521

1.02

0.07

3.9

3.2

29.94

27.48

mg/l

0.28

946

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

177

1.07

0.06

1.5

1.2

2.55

339.86

ug/l

1.52

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

100

0.90

0.06

1.2

1.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

106

1037

1.02

0.06

1.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

384

1.04

0.06

31.5

26.2

121.91

116.24

ug/l

0.19

320

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

109

1.10

0.06

1.7

3.4

—

(3026250) Tacrolimus [Mass/volume] in Blood

375

0.96

0.05

29.1

34.1

7.66

7.35

ug/l

0.45

340

(3034426) Prothrombin time (PT)

312

0.96

0.04

1.4

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

318

1.04

0.04

1.2

5.8

6465.75

2135.99

mg/l

0.29

227

(3014599) Egg white IgE Ab [Units/volume] in Serum

477

1.03

0.04

1.0

0.84

0.75

u/ml

—

101

(40758558) Short blood count panel - Blood

1939

19343

1.00

0.04

5.8

7.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

121

1.07

0.03

1.1

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

668

1.02

0.03

1.1

—

(3017569) Oxygen content in Arterial blood

319

0.97

0.02

3.0

2.3

—

(3036489) Thrombin time

294

2954

1.00

0.02

1.6

2.0

21.03

21.23

0.26

235

2561

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

103

1.07

0.02

1.0

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

173

1.04

0.01

1.1

1.2

106.00

79.66

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

407

4080

1.00

0.01

2.3

3.5

23.58

52.11

u/ml

10.35

390

3943

(3051101) Glucose [Moles/volume] in Cord blood

114

1.05

0.00

4.0

6.1

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

173

0.98

0.00

1.4

24.36

23.07

0.06

155

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

484

0.99

0.00

1.4

1.6

7.03

6.07

u/l

0.30

397

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

155

0.97

0.00

1.4

—

(3029396) Erythrocyte agglutination [Presence] in Blood

165

1.03

0.00

2.6

2.8

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

305

1.02

0.00

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

315

1.02

0.00

1.6

2.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

151

0.99

0.00

1.0

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.01

0.00

1.5

1.2

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.1

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

7.9

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.00

-0.00

1.2

1.1

—

(3009992) Blasts/100 cells in Bone marrow

0.00

-0.00

0.0

2.0

—

10.71

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.2

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

0.97

-0.00

1.7

2.04

1.53

mg/l

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.93

-0.00

1.6

1.4

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

28.65

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

0.89

-0.00

1.2

1.5

15.36

25.32

pmol/l

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.97

-0.00

1.6

2.4

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

-0.00

0.0

1.0

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_ROOTPLEXOTHUNS and mortality.

Females

Parameter	HR [95% CI]	p-value
G6_ROOTPLEXOTHUNS	1.116 [1.01, 1.24]	0.034
Birth year	0.994 [0.99, 1.0]	0.182

During the follow-up period (1.1.1998 — 31.12.2019), 1878 out of 17306 females with G6_ROOTPLEXOTHUNS died.

Males

Parameter	HR [95% CI]	p-value
G6_ROOTPLEXOTHUNS	1.143 [1.03, 1.27]	0.011
Birth year	0.984 [0.98, 0.99]	0.001

During the follow-up period (1.1.1998 — 31.12.2019), 2262 out of 17987 males with G6_ROOTPLEXOTHUNS died.

Mortality risk

Mortality risk for people of age

years, who have G6_ROOTPLEXOTHUNS.

N-year risk	Females	Males
1	0.09%	0.202%
5	0.549%	1.193%
10	1.621%	2.904%
15	3.157%	5.689%
20	5.518%	9.527%

Relationships between endpoints

↥

Index endpoint: G6_ROOTPLEXOTHUNS – Other and unspecified nerve root and plexus disorders, also in other diseases

GWS hits: 2

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other and unspecified nerve root and plexus disorders, also in other diseases

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints